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A case of persistent hyperparathyroidism after
conventional neck exploration: an unexpectedly simple
solution to a difficult problem
1
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A 57-year-old man was referred to the University Medical Center Utrecht with per-
sistent hypercalcemia after a bilateral neck exploration for primary hyperparathy-
roidism (pHPT). The operative notes were reviewed and showed that a thorough
and systematic procedure had been performed. During the initial exploration a nor-
mal superior parathyroid gland had been identified on the right side of the neck;
this was left in situ. A second, slightly enlarged, inferior gland at the same side
was resected. On the left side of the neck the superior gland was judged to be nor-
mal, but notwithstanding all efforts including thymectomy and thyroidotomy, the
inferior gland on this side could not be found, whereafter the exploration was dis-
continued. Persistent hypercalcemia postoperatively indicated that the causative
adenoma had not been identified. Upon referral to our hospital the diagnosis pHPT
was confirmed biochemically. Since the patient was symptomatic (nephrolithiasis)
with elevated serum calcium levels of 2.95 mmol/L (normal range 2.20-2.60) the
indication for reoperation was unavoidable. The initial work-up, as usual for reop-
erative cases in our institution, consisted of Doppler ultrasonography (US), spiral
computed tomography (CT), magnetic resonance imaging (MRI), thallium201-
technetium-Tc99m pertechnetate scanning (ThTc) and selective venous parathor-
mone (PTH) sampling. Relying upon the information gained at first exploration, the
test results were studied with special attention for the left side of the neck and
mediastinum. None of the test results showed any evidence of an adenomatous
lesion in the mediastinum. Selective venous PTH sampling showed increased lev-
els of PTH at multiple levels on the right side and only one selective high level of
PTH on the left side of the neck. Because this was contrary to what we expected,
the possibility of a third gland on the right side was considered. The only positive
added value of venous PTH sampling was the presumed cervical (and not medi-
astinal) location of the lesion. MRI did not show any evidence of an adenoma.
Ultrasonography was negative except for one lesion ventral to the carotid sheath at
the level of the mandibular angle and the hyoid bone on the left side. The location
of this 2-cm oval shaped lesion was typical for a lymphnode. However its intense
Doppler flowpattern was atypical for the ultrasonographic characteristics of lym-
phatic tissue. Therefore, we decided to complete the analysis with fine needle
aspiration. Microscopy irrefutably proved the nature of the mass: parathyroid tis-
sue. Revision of the CT images revealed an ectopic adenoma at the location indi-
cated by US, which had been missed during the first evaluation (Figure 1). Since
the lesion was now proven to be the fourth (missing) parathyroid gland we focused
on this lesion alone. The operative plan consisted of a local procedure at the indi-
cated site. A small incision was made at the ventral border of the sternocleidomas-
toid muscle at the level of the hyoid bone. After only a few minutes of exploration a
well vascularised, red-brownish, oval shaped lesion (macroscopically a parathyroid
adenoma) was found in the direct vicinity of the submandibular gland. Once the
lesion was resected the exploration was terminated. Postoperatively, the calcium
level had returned to normal on day one. Histological examination of the specimen
2
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confirmed the diagnosis: parathyroid tissue. Currently, more than 6 years post-
resection, the patient is still normocalcemic.
After a thorough and systematic exploration performed by an experienced
endocrine surgeon, persistent hyperparathyroidism still cannot be precluded in all
patients as is illustrated by this case. These complications in parathyroid surgery
are mostly caused by the variability in location of the glands, rather than by the
variety in the number of affected glands. The majority of ectopic parathyroids (ade-
nomas), however, can be found in the vicinity of the lower pole of the thyroid and
upper part of the thymus. A rule of thumb is that the further the distance from
parathyroid to thyroid the lower the frequency of ectopic parathyroid tissue. A
parathyroid adenoma located at the level of the hyoid bone, as in the case present-
ed, is extremely rare (<0.1%) 1 2. This can be explained by the fact that -in con-
trast to the superior parathyroid gland whose position remains relatively constant-
the inferior parathyroid gland travels a long distance during fetal development
CHAPTER 1 I INTRODUCTION, A CASE OF PERSISTENT HYPERPARATHYROIDISM
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Figure 1 Cross section image of Computed Tomography showing an adenoma at the level
the hyoid bone. Adenoma (A), hyoid bone (H), common carotid artery (CC), internal jugular
vein (JV), facial vein (FV), sternocleidomastoid muscle (SM).
H
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together with the thymus and may thus be found anywhere from the angle of the
jaw to the pericardium (Figure 2). In a case when the migration of the parathyroid
gland is interrupted during development one speaks of a non-descended parathyroid.
The quality and reliability of imaging modalities have improved substantially over
the last decade. In this case the missing adenoma was ultimately found on US per-
formed by an experienced, persistent radiologist. All other localizing studies were
negative, but for CT. The adenoma was initially overlooked in the CT examination
because of its rare ectopic position, rather than its radiological characteristics. The
selective venous PTH sampling was inconclusive. With hindsight, the combination
of US and CT convincingly localized the adenoma, even in a most surprising position.
4
Figure 2 Descent of the inferior parathyroid gland. The inferior parathyroid gland migrates
during fetal life and may end up anywhere along the path of descensus (black line). 
Adapted from Kaplan EL. Thyroid and parathyroid. Chapter 38. Schwartz SI, ed. Principles
of Surgery, 5th edition. New York: Mc Graw-Hill, 1989; 1613-1685.
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In this case the transition from failure to success was realized by a minimally inva-
sive, local procedure relying upon state-of-the-art imaging technology and a direct
approach to the lesion. Based on the success of this relatively simple and quick
procedure we wondered whether such a direct, minimally invasive strategy could
be utilized for the ‘standard’ case of pHPT as well. We speculated that it might
serve as an alternative for the conventional neck exploration. The results of this
speculation are reported in this thesis.
CHAPTER 1 I INTRODUCTION, A CASE OF PERSISTENT HYPERPARATHYROIDISM
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Standard surgical treatment of primary
hyperparathyroidism until the 1990s:
Conventional Neck Exploration
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Introduction
Sandström 1 first described a small gland located in the vicinity of the thyroid gland
in 1880 and gave it the name of ‘glandula parathyroidea’. The first anatomic
description in humans was published by Welsh 2 in 1898, and by Halsted and
Evans 3 in 1907. After the first successful parathyroid operation was performed by
Doctor Felix Mendl in Vienna in 1925 for a patient with primary hyperparathy-
roidism (pHPT) and osteitis fibrosa cystica, parathyroidectomy has been the treat-
ment of choice for patients with pHPT 4. It was not until the late 1960s that most
cases of pHPT were detected by routine biochemical screening rather than
because of specific associated symptoms or complications such as renal colic,
parathyroid bone disease, peptic ulcer disease, gout, or pancreatitis. Routine mul-
tichannel biochemical screening of serum calcium came to widespread use at the
beginning of the 1970s, resulting in a rapidly increasing total number of patients
diagnosed with mild to moderate hypercalcemia. Primary hyperparathyroidism is
nowadays the most common cause of hypercalcemia in nonhospitalized patients
and, along with (dissiminated) cancer, accounts for 90% of all patients with hyper-
calcemia 5.
Clinical Presentation and Diagnosis
Most patients are detected by routine screening before presenting with (severe)
clinical symptoms. The diagnosis pHPT is based upon documentation of persistent
hypercalcemia and elevated parathyroid hormone (PTH) level without hypocalci-
uria. Immunoassays for intact PTH using double-antibody methods are highly sen-
sitive and represent a major advance in the diagnostic process 6. The majority of
patients with pHPT have unequivocal elevated PTH levels, whereas patients with
hypercalcemia from other causes, such as malignancy and sarcoidosis have low,
normal, or suppressed values 6. Other tests that sometimes are useful (but not
diagnostic) are the blood alkaline phosphatase level, which is elevated in high
turnover parathyroid bone disease and the blood phosphate level which is
decreased in about 50% of patients with pHPT. This, simultaneously with an
increased blood chloride level (in about 40% of patients) elevates the
chloride/phosphate ratio in most patients 7.
The clinical manifestation of pHPT varies from asymptomatic disease to a picture
which has been described as ‘painful bones, kidney stones, abdominal groans,
psychic moans, and fatigue overtones’. Most patients (about 80%) are diagnosed
8
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with pHPT without having any symptoms or with subtle symptoms as fatigue and
muscular weakness. Table 1 shows the spectrum of symptoms which may be
present in pHPT.
Anatomy and Embryology
The superior parathyroid glands originate along with the lateral lobes of the thyroid
(ultimobranchial body) from the dorsal tips of the pharyngeal fourth pouch. Because
the superior glands migrate only slightly their position is relatively constant, cephalad
to the inferior thyroid artery and dorsal in respect to the recurrent laryngeal nerve. The
inferior glands arise along with the thymus from the dorsal part of the third branchial
pouch and migrate downward during fetal life. The position of the normal inferior
parathyroid gland is less constant because it travels so far in embryonic life. It can be
found anywhere from the angle of the jaw to the pericardium, but is found caudal to
the inferior thyroid artery and ventral to the recurrent laryngeal nerve in approximately
55% of cases 8. In addition, enlarged parathyroid glands may migrate secondarily in
adult life and become ectopic. The superior gland tends to fall back and displace in a
posterior and caudal direction. It descends along the tracheo-esophageal groove even
CHAPTER 2 I CONVENTIONAL NECK EXPLORATION
9
Table 1
Symptoms in patients with primary hyperparathyroidism.
Bone Pain
Constipation
Depression
Exhaustion
Fatigue
Joint pain
Loss of appetite
Memory loss
Nausea
Nocturia
Poliuria
Polydipsia
Renal colic
Weakness
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as deep as the posterior mediastinum. The inferior parathyroid gland tends to move in
an anterior-caudal direction and may descend in the anterior mediastinum 9.
The average weight of a normal parathyroid gland is 35-50 mg. Parathyroid glands
are small (2-5 mm), usually yellowish-brown and sometimes look like fat, which
make them difficult to find for the inexperienced operator. In approximately 75% of
cases the superior gland is to be found on the posterior portion of the middle third
of the thyroid. As already indicated the position of the normal inferior gland is
more variable and can be found in approximately 75% of cases on the lateral or
posterior surface of the lower pole of the thyroid gland, or not more than 0.5 cm
below the lower pole 10 (Figure 1).
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Figure 1 The relative frequency with which the parathyroid glands are found in the various 
locations. The superior gland is usually (75%) found on the posterior portion of the middle
third (B) of the thyroid. In about 9% the gland is found more cephalad at the upper pole (A)
of the thyroid. The location of the inferior gland is more variable; approximately 55% is
found on the posterior surface of the lower pole (C), 25% below the lower pole (thymus or
lower) (D), 10% deep medio-posterior of the thyroid (E).
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Parathyroidectomy
Surgery offers the only definitive treatment for patients with pHPT 11. The primary
goal of parathyroidectomy is to establish normocalcemia with minimal complica-
tions (these include persistent or recurrent hyperparathyroidism, postoperative
transient or persistent hypoparathyroidism, and recurrent laryngeal nerve injury).
The gold standard in parathyroid surgery is the conventional neck exploration
(CNE), a very safe procedure with success rates exceeding 95% and minimal mor-
bidity (Table 2) 12 13 14 15 16. The most important variable that influences the success
of parathyroidectomy is the experience of the surgeon. The rate of persistent hyper-
parathyroidism can be as high as 30% in less experienced hands 17.
Conventional neck exploration is preferentially performed under general anesthesia
with endotracheal intubation. The patient is positioned in supine position, the neck
extended dorsally to provide maximal access to the neck. A low, symmetric Kocher
transverse incision is made 3 to 4 cm cranial to the suprasternal notch. After inci-
sion of the platysma muscle, the strap muscles (m. sternohyoid, m. sternothyroid)
are divided in the median raphae, separated from each other and may be cleaved.
The sternocleidomastoid muscle and internal jugular vein are lateralized. The fas-
cia between common carotid sheath and thyroid is opened alongside the carotid
artery in order to mobilize the thyroid gland in medioventral direction, whereafter
the loose areolar tissue of the tracheoesophageal groove is entered. Care is taken
in identifying the delicate recurrent laryngeal nerve.
After identification of the four parathyroids, the adenoma(s) is resected and sent
for histological examination. The assessment whether a parathyroid is normal or
diseased is determined by the surgeon and is based upon macroscopical features
such as size and color. Some authors rely on microscopical features in frozen sec-
tion to distinguish adenomas from hyperplastic glands 18 19. However, no single cri-
terium has irrefutably proven to be useful in discriminating between adenoma and
hyperplasia 20. Therefore, we agree with the statement that the role of the patholo-
gist intraoperatively is limited simply to the identification of parathyroid tissue 21.
Difficulties associated with parathyroid surgery relate to the variety in location, and
to a lesser extent, the number of the (diseased) glands, and to the problem of dif-
ferentiating normal glands from slightly diseased ones. In an extensive postmortem
study Gilmour 22 found that 80% of individuals had four parathyroids, 6% had five
and 13% had three. Others report different frequencies of supernumerary glands:
Boyd 23 found five or six glands in 14%, Alveryd 24 reported fewer than four glands
in less than 1%. Without neglecting these figures, it is of utmost importance to
identify four parathyroids. Even if an adenoma and two normal parathyroids are
identified the surgeon should endeavor to find the unidentified parathyroid,
CHAPTER 2 I CONVENTIONAL NECK EXPLORATION
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because missing at its normal localization can indicate a migrated second enlarged
parathyroid. If during exploration one or more parathyroids are missing or the ade-
noma cannot be found the following rules should be remembered. Firstly, as has
been succinctly stated by Rothmund 25, the majority of all parathyroids are located
within a 1-2 cm circle around the intersection of the inferior thyroid artery and the
recurrent laryngeal nerve. The superior gland situated cephalad to the artery and
dorsal in respect to the nerve, the inferior caudal to the artery and ventral to the
nerve 26. Secondly: it may be assumed that the gland on the contralateral side is
located symmetrically to the one found at the ‘identified side’. Thirdly: If the miss-
ing adenoma is of superior origin, the space dorsal to the thyroid gland and the
oesophagotracheal groove should be explored. The common origin of the superior
parathyroid and thyroid accounts for the occasional intrathyroidal location found in
less than 1% of all cases 25 26. The tongue of the thymus (thyrothymic ligament)
should be explored for a missing inferior gland since this is the second most com-
mon location after the lower pole of the thyroid. If the adenoma is still missing
after thymectomy an intrathyroidal parathyroid should be considered necessitating
thyroidotomy or lobal thyroidectomy. However rare, a missing inferior adenoma
can be found anywhere along the path of descensus, from the angle of the jaw to
the pericardium 10 25. Finally, a primary sternotomy should only be considered after
a thourough, systematic, but negative exploration in patients with life threatening
hypercalcemia 27.
A major and recurrent problem during exploration is the differentiation between an
adenoma and a hyperplastic gland, or single gland disease from multiple gland dis-
ease. Since microscopic examination durante operationem is of no added value,
making decision relies upon the macroscopic features and thus on the surgeon’s
judgement and experience. Classically, an adenoma has been defined as an enlarged
gland with a rim of normal tissue. However, this histological appearance can be
found in cases of hyperplasia as well. Significant differences in histological appear-
ance could not be demonstrated in 236 patients with pHPT by Bonjer et al 20.
CHAPTER 2 I CONVENTIONAL NECK EXPLORATION
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Preoperative Imaging Studies
Numerous localization techniques have been used to identify the site of the abnor-
mal parathyroid gland preoperatively, including ultrasonography (US), computed
tomography (CT), magnetic resonance imaging (MRI), thallium201-technetium-
Tc99m pertechnetate scanning (ThTc) and sestamibi-technetium99m scintigraphy
(Sestamibi), and selective venous catherization for measurements of PTH levels.
High-resolution ultrasonography is easy to perform and is well tolerated by the
patient. It does not require injection of contrast, does not emit radiation, can be
done quickly and is inexpensive. Unfortunately, the retrosternal, retroesophageal,
retrotracheal and deep cervical glands are difficult to locate by US. The sensitivity
varies according to the ultrasonographer’s experience, the frequency of the trans-
ducer, the resolution of the image, and the size of the parathyroid gland 28.
Computed tomography is relatively expensive, exposes the patient to radiation, and
requires administration of (a) contrast agent(s) to obtain the highest resolution.
The sensitivity of CT reportedly ranges from 41 to 86%, as compared to 57-90%
29 32 for MRI. Other advantages of MRI over CT are that the use of contrast is avoid-
ed and shoulder artefacts are not a problem.
Thallium201-technetium-Tc99m pertechnetate scanning is reported to be moder-
ately accurate with sensitivity rates ranging 25 to 70% 29 33, whereas Sestamibi is
superior with reported sensitivity rates reaching 100% in solitary disease 34 35.
Radionuclide scintigraphy is associated with low risk and minimum irradiation,
and is minimally operator dependent. However, due to the high cost, its use should
be restricted to a selected group of patients.
Selective PTH sampling is an invasive, expensive localization method requiring an
expert radiologist. This method should, therefore, be limited to the reoperative
case.
Progressive development of imaging modalities over the last ten years have made
the various techniques increasingly reliable. The pace technical development
should raise the accuracy and sensitivity rates of localization studies and antici-
pates future image-guided surgical procedures.
14
02. hoofdstuk 02  23-07-2001  10:05  Pagina 14
Discussion
Since pHPT can be diagnosed with nearly 100% accuracy and successfully treated
in more than 95% of patients, surgery is the choice of treatment. Until now the
gold standard in parathyroid surgery has been CNE. Routine localization studies
are of no added value, since sensitivity rates in localizatory studies (reaching 85%
maximum) are inferior to success rates in CNE 38. Furthermore, accuracy of imag-
ing techniques decreases in multiglandular disease and is therefore of little use in
predicting whether a patient has uniglandular or multiglandular disease 29 31 39.
Preoperative localization may even mislead the less experienced surgeon, who
might fail to identify all involved parathyroid glands 35.
With success rates exceeding 95% and virtually no complications nothing more
seems to be desired. Nevertheless, since the early 1980s authors have been
increasingly propagating less invasive techniques 36 37 (unilateral exploration), in
order to reduce operation time and admission days, decrease operative risk during
reexploration and to obtain better cosmetic results. They rely upon the high inci-
dence of solitary adenoma (approximately 85%) and improved resolution in preop-
erative imaging modalities. ‘Bilateralists’ however, oppose such an approach
because of the incidence of multiple gland disease which may be, in their opinion,
as high as 30% 13. Furthermore they are critical as far as the accuracy of localiza-
tion procedures is concerned.
The ability to document PTH concentration during operation, first described by
Nusbaum 40, was further developed in the early 1990s. The use of an intraopera-
tive PTH assay could prove beneficial in the surgical management of pHPT. The
biochemical confirmation of complete removal of all hyperfunctioning tissue allows
less than bilateral neck explorations. Despite their helpfulness, these intraoperative
assays have not gained widespread acceptance. The short half-life of isotopes and
thus limiting shelf-life of these intraoperative PTH assays; the necessary safety
precautions (including proper disposal of waste products); a false negative rate of
15%; and high costs initially limited its use to a few specialized centers 37.
The diagnosis pHPT is based upon biochemically proven hypercalcemia with inap-
propiate high levels of PTH. The treatment of choice is CNE, a highly effective pro-
cedure associated with minimal morbidity. However, because pHPT is caused by a
solitary adenoma in at least 85%, and presently available localization procedures
are increasingly accurate, unnecessary extensive dissection is undertaken in the
vast majority of patients. The ability to ascertain success of parathyroidectomy by
presently available reliable and affordable intraoperative PTH assays will lead
undoubtedly towards more limited forms of parathyroidectomy.
CHAPTER 2 I CONVENTIONAL NECK EXPLORATION
15
02. hoofdstuk 02  23-07-2001  10:05  Pagina 15
References
1 Sandrström I. Om en ny körtel hos människan och åtskilliga däggdjur. Uppsala Läk-
Fören Förh 1879-80; 15: 441-471
2 Welsh DA. Concerning the parathyroid glands: a critical anatomical and experimental
study. J Anat Physiol 1898; 32: 292-307
3 Halsted WS, Evans HM. The parathyroid glandulas: their body supply, and their preser-
vation in operation upon the thyroid gland. Ann Surg 1907; 46: 489-501
4 Goldman L, Gordon GS, Roof BS. The parathyroids. Cur Prob Surg. St Louis, Mosby;
1971: 1-64
5 Clark OH. Management of primary hyperparathyroidism. Adv Endocrinol Metab 1995;
6: 1-16
6 Budayr AA, Nissenson RA, Klei RF, et al. Increased serum levels of a parathyroid hor-
mone-like protein in malignancy-associated hypercalcemia. Ann Intern Med 1989; 10:
807-812
7 Reeves CD, Palmer F, Bacchus H, Longerbeam JK. Differential diagnosis of hypercal-
cemia by chloride/phosphate ratio. Am J Surg 1975; 130: 166-171
8 Gilmour JR. The embryology of the parathyroid glands, the thymus and certain associ-
ated rudiments. J Pathol 1937; 45: 507-521
9 Curley IR, Wheeler MH, Thompson NW, Grant CS. The challenge of the middle medi-
astinal parathyroid. World J Surg 1988; 12: 818-824
10 Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s; Choice of
surgical procedures for this disease. Ann Surg 1992; 215: 300-317
11 Diagnosis and management of asymptomatic primary hyperparathyroidism. National
Institute of Health Consensus development conference statement. J Bone Miner Res
1991; 6: 59-63
12 Russel CF, Edis AJ. Surgery for primary hyperparathyroidism: experience with 500 con-
secutive cases and evaluation of the role of surgery in the asymptomatic patient. Br J
Surg 1982; 69: 244-247
13 Bruining HA, van Houten H, Juttmann JR, et al. Results of operative treatment of 615
patients with primary hyperparathyroidism. World J Surg 1981; 5: 85-90
14 van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an insti-
tutional perspective. World J Surg 1981; 15: 688-692
15 Saaka MB, Sellke FW, Kelly TR. Primary hyperparathyroidism. Surg Gynaecol Obstet
1988; 166: 333-337
16 Low RA, Katz AD. Parathyroidectomy via bilateral cervical exploration: a retrospective
review of 866 cases. Head and Neck 1998; 20: 583-587
17 Malmaeus J, Granberg PO, Halvorsen J, et al. Parathyroid surgery in Scandinavia. Acta
Chir Scand 1988; 154: 409-413
18 Rudberg C, Akerström G, Palmer M, et al. Late results of operation for primary hyper-
parathyroidism in 441 patients. Surgery 1986; 99: 643-651
16
02. hoofdstuk 02  23-07-2001  10:05  Pagina 16
19 Cooke TJC, Boey JH, Sweeney EC, et al. Parathyroidectomy: extent of resection and
late results. Br J Surg 1977; 64: 153-157
20 Bonjer HJ, Bruining HA, Birgenhager JC, et al. Single and multigland disease in pri-
mary hyperparathyroidism: Clinical follow-up, histopathology, and flow symmetric DNA
analysis. World J Surg 1992; 16: 737-743
21 Nishiyama RH. The intraoperative diagnosis of parathyroid lesions. Acta Chir Aust
1994; 112: 8-14
22 Gilmour JR. The gross anatomy of the parathyroid glands. J Pathol Bacteriol 1938; 46:
133-149
23 Boyd JD. Development of the thyroid and parathyroid glands and the thymus. Ann R
Coll Surg Eng 1950; 7: 455-461
24 Alveryd A. Parathyroid glands in thyroid surgery. I Anatomy of parathyroid glands II
Postoperative hypoparathyroidism, identification and autotransplantation of parathyroid
glands. Acta Chir Scand 1968; 389: 1-120
25 Rothmund M. A parathyroid adenoma cannot be found during neck exploration of a
patient with presumed primary hyperparathroidism. Br J Surg 1999; 86: 725-726
26 Akerström G, Malmaeus J, Bergström R. Surgical anatomy of human parathyroid
glands. Surgery 1984; 95: 14-21
27 Bonjer HJ, Bruining HA. Technique of parathyroidectomy. Clark OH, Duh QY. Textbook
of Endocrine Surgery. Philadelphia: WB Saunders Company; 1997: 347-356
28 Gooding GAW. Sonography of the thyroid and parathyroid. Radiol Clin North Am 1993;
31: 967-989
29 Miller DL. Preoperative localization and interventional treatment of parathyroid tumors:
when and how? World J Surg 1991; 15: 706-715
30 Roses DF, Sudarsky LA, Sanger J, et al. The use of operative localization of adenomas
of the parathyroid gland by thallium-technetium, high-resolution ultrasonography and
computed tomography. Surg Gynecol Obstet 1989; 168: 99-106
31 Krubsack AJ, Wilson SD, Lawson TC, et al. Prospective comparison of radionuclide,
computed tomography and sonographic localization of parathyroid tumors. World J
Surg 1986; 10: 579-585
32 Erdman WA, Breslau NA, Weinreb JC, et al. Noninvasive localization of parathyroid
adenomas: a comparison of X-ray computerized tomography, ultrasound, scintigraphy
and MRI. Magn Reson Imag 1989; 7: 189-194
33 Price DC. Radioisotopic evaluation of the thyroid and parathyroids. Radiol Clin North
Am 1993; 31: 991-1015
34 Thulé P, Tharoke K, Vasant J, et al. Preoperative localization of parathyroid tissue with
technetium-99m sestamibi 123I substraction scanning. J Clin Endocrinol Metab 1994;
78: 77-82
35 Casas AT, Burke GJ, Mansberger AR jr, Wei JP. Impact of technetium-99m sestamibi
localization on operative time and success of operations for primary hyperparathy-
roidism. Am Surg 1994; 60: 12-16
CHAPTER 2 I CONVENTIONAL NECK EXPLORATION
17
02. hoofdstuk 02  23-07-2001  10:05  Pagina 17
36 Tibblin S, Bondeeson AG, Ljungberg O. Unilateral parathyroidectomy in hyperparathy-
roidism due to single adenoma. Ann Surg 1982; 195: 245-252
37 Irvin GL, Prudhomme DL, Deriso GT, et al. A new approach to parathyroidectomy. Ann
Surg 1994; 219: 574-581
38 Roe SM, Burns P, Graham LD, et al. Cost-effectiveness of preoperative localization
studies in primary hyperparathyroid disease. Ann Surg 1994; 219: 582-586
39 Roth SI. Pathology of the parathyroids in hyperparathyroidism: discussion of recent
advances in the anatomy and pathology of the parathyroid glands. Arch Pathol 1962;
73: 495-504
40 Nusbaum SR, Thompson AR, Hutcheson KA, et al. Intraoperative measurement of
parathyroid hormone in the surgical management of hyperparathyroidism. Surgery
1988; 104: 1121-1127
18
02. hoofdstuk 02  23-07-2001  10:05  Pagina 18
Hypothesis and Objectives
3
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Based on the knowledge that in the vast majority (>85%) of patients primary
hyperparathyroidism is caused by a single parathyroid adenoma, and stimulated
by the potential for preoperative localization of present imaging technology (illus-
trated in chapter one) the following hypothesis was formulated:
A substantial group of patients with primary hyperparathyroidism can be success-
fully treated by limited access surgery after preoperative localization studies and
may thus be spared unnecessary extensive dissection (conventional neck explo-
ration).
To confirm this hypothesis the following questions were addressed in the studies
presented in this thesis:
1 a) Is minimally invasive adenomectomy a safe and reliable alternative to con-
ventional neck exploration ?
b) Is minimally invasive adenomectomy associated with higher morbidity com-
pared to conventional neck exploration ?
c) In how many patients can conventional neck exploration be replaced by
minimally invasive adenomectomy ?
(chapter 4: Direct, minimally invasive adenomectomy for primary hyper-
parathyroidism: an alternative to conventional neck exploration ?)
2 Provided minimally invasive adenomectomy is validated as a safe alternative to
conventional neck exploration, would that imply that this technique should be
restricted to symptomatic patients, or should asymptomatic patients also be
considered for this procedure as well ?
(chapter 5: Strategy in asymptomatic and mildly symptomatic primary hyper-
parathyroidism, new arguments for the surgical option)
3 How reliable is Doppler ultrasonography combined with computed tomography,
and Doppler ultrasonography with selective supplemental computed tomogra-
phy in the selection for minimally invasive adenomectomy ?
(chapter 6: Minimally invasive surgery of solitary parathyroid adenomas in
patients with primary hyperparathyroidism; Role of ultrasonography with sup-
plemental computed tomography)
4 a) Will a modification of standardized parathormone assay result in a quick
and reliable assay to ascertain success of parathyroid surgery ?
b) And can it be used on a routinely base in the surgical treatment of primary
hyperparathyroidism ?
(chapter 7: Peroperative PTH testing: confirmation of successful surgical
treatment of primary hyperparathyroidism)
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5 a) How reliable are commercially available non-portable parathormone assays
in predicting surgical outcome ?
b) Can these tests serve as an alternative for (expensive) commercially avail-
able portable assays ?
(chapter 8: Perioperative parathormone assessment during surgery for primary
hyperparathyroidism; Comparison of four techniques)
6 a) What are the costs of minimally invasive adenomectomy and conventional
neck exploration, taken from a hospital point of view ?
b) Which appreciable variables can be identified and what is the degree of
change required to eliminate differences in costs ?
(chapter 9: Cost-analysis of minimally invasive surgery and conventional neck
exploration for primary hyperparathyroidism)
CHAPTER 3 I HYPOTHESIS AND OBJECTIVES
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Direct, minimally invasive adenomectomy for 
primary hyperparathyroidism:
An alternative to conventional neck exploration ?
Smit PC, Borel Rinkes IHM, van Dalen A, van Vroonhoven TJMV. Direct, minimally invasive adenomectomy
for primary hyperparathyroidism: an alternative to conventional neck exploration ? Annals of Surgery 2000 ;
231 : 559 - 565
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Abstract
Objective  To evaluate the feasibility and efficacy of a direct, minimally invasive ade-
nomectomy (MIA) as an alternative to conventional neck exploration (CNE) in
patients with primary hyperparathyroidism.
Summary Background Data  Because primary hyperparathyroidism is caused by a soli-
tary adenoma in 85 to 90% of patients, a direct adenomectomy through a mini-
incision would theoretically suffice whenever an adenoma is correctly localized on
preoperative imaging. If effective, a less invasive method could spare the patient
an unnecessary bilateral neck exploration, thus saving time and rendering future
surgical procedures in the neck less problematic.
Methods  Between October 1994 and October 1998, 110 consecutive patients with
biochemically proven primary hyperparathyroidism who were to undergo surgery
were enrolled in this study. Ultrasound and spiral CT were routinely performed as
standard preoperative imaging modalities in the first series of 65 patients. In the
second series of 45 patients, ultrasound was performed as a sole initial modality;
it was supplemented by CT only in case of inconclusive test results. If test results
were unequivocal (one adenoma) the patient was offered MIA. CNE was performed
if the results were equivocal or if multiglandular disease was suspected.
Results  Overall, 84 patients were selected for MIA and 26 for CNE. In the first
series, 2 MIA procedures (2/51) were converted to CNE because of negative peri-
operative findings. All 65 procedures resulted in normocalcemia. In the second
series, all but 5 (4/33 MIAs, 1/12 CNEs) resulted in normocalcemia. A reexplo-
ration (CNE) was performed in three patients, resulting in normocalcemia after
resection of a second or third adenoma. Two patients are still awaiting reexplo-
ration. In both series together, 78 of the 110 patients were successfully treated
with MIA and spared a CNE.
Conclusion  MIA is a safe and effective alternative to CNE that may replace CNE in
approximately two thirds of all patients.
24
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Introduction
Conventional treatment for primary hyperparathyroidism (pHPT) consists of sys-
tematic bilateral neck exploration, identification of all parathyroid glands, and
removal of all pathologically enlarged, hyperfunctioning parathyroid tissue 1.
Because this conventional neck exploration (CNE) is associated with a minimal death
rate, a low complication rate, and cure rates of 90 to 97%, it is generally considered
an effective and safe procedure leaving little room for improvement 1 2.
However, various authors have confirmed that pHPT is caused by a solitary adeno-
ma in 85 to 90% of cases 1 2 3 4. In these patients, removal of the affected parathy-
roid gland alone through a mini-incision, would theoretically suffice. Thus,
unnecessary exploration of normal parathyroids, making subsequent surgery in the
thyroid region unattractive and more prone to complications, might be avoided.
Few reports have been published on strategies of less invasive surgery for pHPT,
most of which have included unilateral exploration 5 6. Only the study of Chapuis et
al. 3 describes a truly minimally invasive strategy, with mini-incision over the ade-
noma. Using this procedure, the authors reported they could avoid CNE in approx-
imately 40% of their patients.
Clearly, for such a direct, minimally invasive adenomectomy (MIA) to be success-
ful, optimal preoperative imaging is a prerequisite. This imaging should not only
accurately localize pathologically enlarged parathyroid glands, but should also be
capable of aiding in the selection of patients for the direct approach by differentia-
ting between solitary and multiglandular disease. Although many imaging tech-
niques have been reported for visualization of hyperfunctioning parathyroids, with
varying degrees of success, none has proved sufficiently accurate to revolutionize
surgical management in patients with pHPT, with the exception of reoperations 7 8.
Nevertheless, recent work from our group has indicated that preoperative imaging
by combined ultrasonography and CT scanning, including the use of cinevision
technology, appears to be able to improve sensitivity and specificity rates to
acceptable levels 4. The present study represents a prospective evaluation of MIA
in over 100 patients with pHPT. Initially, combined imaging was used routinely. In
the second group of patients, we tried to determine whether ultrasound could be
used as the sole initial imaging modality, basing the need for subsequent CT scan-
ning on the ultrasound findings.
CHAPTER 4 I MINIMALLY INVASIVE ADENOMECTOMY
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Methods
Patients
Consecutive patients with biochemically proven pHPT who were to undergo sur-
gery were enrolled in this prospective study. Informed consent was obtained.
Patients with previous (para)thyroid surgery were excluded. Between October
1994 and October 1998, 110 patients with pHPT were included. The investigated
group involved 27 male patients and 83 female patients with a median age of
59.5 years (range 17-84). The median serum calcium level was 2.85 mmol/L
(2.35-3.80; normal 2.20-2.60) and the median serum parathyroid hormone
(PTH) was 12.8 pmol/L (4.9-234; normal <8 in normocalcemic state). All
patients underwent preoperative parathyroid imaging.
In the first series of 65 patients (group A), both ultrasonography and CT scanning
of the neck were routinely performed as standard preoperative imaging modalities.
In the second series of 45 patients (group B), ultrasound was done as the sole ini-
tial imaging modality. When the ultrasound results were inconclusive, additional
CT scanning was performed. The imaging data of each individual patient were
thoroughly discussed by the radiologist and the surgeon. If there was unequivocal
radiologic identification of a solitary adenoma, the patient was offered an ade-
nomectomy with MIA. In contrast, when the test results were equivocal, or if
multiglandular disease was suspected, the patient underwent a systematic bilater-
al neck exploration. This protocol has been described elsewhere 9. An exploration
was defined as being successful when a normocalcemic state (or hypocalcemia)
was documented on the first postoperative day and confirmed after a minimal fol-
low-up of 1 month. The preoperative findings on imaging were compared with intra-
operative observations and postoperative test results (eg serum calcium, histology).
Ultrasound examinations were performed using a high-end real time unit (ATL,
HDI 900 and 3000, Transducers L5-10 and L7-4; Advanced Technical
Laboratories, Bothell, Washington, USA) with color Doppler mode. All examina-
tions were performed by the same experienced radiologist (AvD). The patient was
positioned in the same way as for surgery: in supine position with the neck in
hyperextension. Modern ultrasound systems with their discriminatory capacity of
structures measuring 3 mm or more, still cannot visualize normal parathyroid
glands. However, enlarged, hyperfunctional parathyroids can be discerned not only
on the basis of their size and oval shape, but also because of their characteristic
ultrasound features, including hypoechogenicity, typical intraglandular blood flow,
movability, and non-compressibility 4. All ultrasound findings regarding the loca-
tion, size and shape of each parathyroid (adenoma), concomitant thyroid disease,
26
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and other abnormalities were recorded and stored in a database.
Spiral CT scanning (Tomoscan 7000; Philips Medical Systems, Eindhoven, The
Netherlands) was performed after intravenous administration of a contrast bolus
(90 mL Isovist 300 (Schering M, Berlin, Germany); rate 2 mL/sec, delay 25 sec)
using a slice thickness of 5 mm and a reconstruction index of 3 mm. Again,
parathyroid adenomas were recognized partly by their anatomical position and
partly by their vascularity. Essential additional information was obtained from
image analysis at the computer workstation (Easy Vision, Philips Medical Systems,
Best, The Netherlands). This allows reconstruction of a scanned volume in the cine
loop motion. With this dynamic reconstruction, it is possible to go up and down
through the scanned volume, making it easier to identify anatomical details that
would otherwise be difficult to discern.
All explorations were carried out under general anesthesia by the same surgical
team. The duration (incision to closure) of each exploration was monitored, togeth-
er with the exact position of the excised structure.
Minimally invasive adenomectomy was performed through a 2-cm-long transverse
incision at the medial border of the sternocleidomastoid muscle, precisely over the
site where the enlarged gland had been located by preoperative ultrasound. With
the sternocleidomastoid muscle and internal jugular vein retracted laterally, and
the strap muscles medially, the thyroid gland was grasped in Ellis forceps and held
in medioventral direction. This allowed the surgeon to reach the loose areolar tis-
sue of the tracheoesophageal groove (Figure 1). After identification of the enlarged
gland, it was excised in toto and its vascular pedicle ligated. No wound drains
were used. Conventional neck exploration was carried out through a transverse col-
lar incision. A bilateral, systematic exploration was done identifying as many
parathyroid glands as possible before removal of the enlarged, hyperfunctioning
gland or glands. Surgical findings, including the size, weight, and location of each
gland excised, were noted before preparation for histological examination.
Immediately after surgery, blood samples were taken at regular intervals.
Procedure-related complications were documented and followed in time. Patients
were discharged as soon as their clinical condition permitted; one criterion for dis-
charge was a serum calcium level of 2.20 mmol/L or more, which was generally
achieved on the first or second postoperative day. All patients were seen on follow
up visits after 1 week and 1 month; after that, follow-up was continued by the
patient’s physician. At one month after surgery, the surgical procedure was deter-
mined to be successful or unsuccessful, as defined above. If hypercalcemia persist-
ed, the patient was scheduled to undergo a reexploration.
Recently, we have developed a rapid PTH test for intraoperative assessment 10. 
CHAPTER 4 I MINIMALLY INVASIVE ADENOMECTOMY
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Figure 1 Cross section images of spiral CT scanning (A) and corresponding schematic draw-
ings (B, C) to depict the route used for the direct approach of a parathyroid adenoma. (B)
Lateral retraction of sternocleidomastoid muscle (SM). (C) Lateral retraction of SM plus
internal jugular vein (JV), and medioventral retraction of the right lobe of the thyroid gland
(T), allows direct approach (downward arrow) of a parathyroid adenoma (A). C, common
carotid artery.
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This is useful, because the half-life of this hormone is approximately 5 minutes.
The test involves a modification of the computerized immunometric method using
chemoluminescence for detection. Although this test was not a subject of the pres-
ent study, with the use of this test surgery was found to have failed in some of the
patients later in this series, and could, therefore, undergo immediate conventional
reexploration.
Although all resected parathyroid glands were examined histologically, histological
classification as ‘adenoma’ or ‘hyperplasia’ has been found to correlate poorly with
‘single’ versus ‘multiglandular’ disease 11. In fact, earlier work has shown that the
distinction between the two entities may be suppositional 12 13. Based on these
observations, we defined each enlarged, hyperfunctioning parathyroid gland as
adenoma for the purpose of this study.
Results
Overall, 84 patients underwent MIA and 26 CNE. Table 1 lists the main character-
istics of each procedure. Two patients who underwent MIA had transient neuro-
praxia of the ipsilateral recurrent laryngeal nerve lasting approximately 2 and 5
months. Both patients had large adenomas in the lower region of the neck. Oral
supplementation for transient hypocalcemia was required in five 5 patients (two
after CNE, three after MIA). On follow-up at 1 week and 1 month after surgery,
serum calcium levels were similar to those on day 1. So far, no late recurrences
have been identified after a median follow-up of 23.5 months (range 4-48).
The excised adenomas varied from 90 to 16,020 mg (median 560; normal <40
mg). All resected adenomas were confirmed histologically. Table 2 shows the num-
ber of adenomas retrieved in each treatment group. Ninety percent of the patients
in this series had solitary adenomas; 10% had multiple adenomas.
In group A, all 65 patients underwent ultrasound investigation according to proto-
col. Four patients did not have spiral CT scanning because of pregnancy or claus-
trophobia. Based on unequivocal localization and identification of a solitary
adenoma on imaging, 51 patients were selected for MIA. The remaining 14
patients underwent CNE. Because of negative perioperative findings, two MIA pro-
cedures were converted into CNE. In one instance, the causative adenoma was
found in a different location than predicted on imaging, as a result of significant
multinodular enlargement of the thyroid. The adenoma in the second patient was
localized correctly, but missed during MIA. All 65 procedures resulted in normocal-
cemia at 1 day, 1 week and 1 month after surgery (Table 3). Nine patients who
CHAPTER 4 I MINIMALLY INVASIVE ADENOMECTOMY
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were selected for CNE actually had solitary adenomas. Thus, combined imaging
with ultrasound and CT (including cinevision) had a sensitivity of 84%, a specifici-
ty of 72%, and a positive predictive value of 96% (Table 4).
In group B (n=45), a supplementary spiral CT was performed in 27 patients
because of inconclusive test results on ultrasonography. In the other 18 patients a
solitary adenoma was diagnosed on ultrasound, and MIA was advised. After CT
30
Table 2 Number of enlarged parathyroid glands (adenomas) retrieved. 
Number of enlarged glands
Procedure 1 ≥ 2 total
MIA* 81 3 84
CNE† 18 8 26
Total 99 11 110
*MIA= minimally invasive adenomectomy, †CNE= conventional neck exploration.
Numbers represent numbers of patients.
Table 1 Treatment characteristics.
MIA CNE
Patients (n) 84 26
Operating time 20 [8-35] 80 [20-120] p<0.05
Hospital stay 1.7 [1-5] 3.0 [1-8] p<0.05
Complications
Transient RLN*-neuropraxia 2 -
Transient hypocalcemia 2 3
Serum calcium level (mmol/L)
Before surgery 2.85 [2.35-3.55] 2.82 [2.50-3.80]
1 day after surgery 2.25 [1.61-2.80] 2.29 [1.83-2.61]
Data are presented as median values [range].
*RLN= recurrent laryngeal nerve.
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scanning, another 15 patients were selected to undergo MIA; the remaining 12
underwent CNE (Table 5). In this group, MIA was unsuccessful in four patients,
three of whom had undergone ultrasonography as the sole preoperative imaging
modality. Two of those in whom surgery failed were identified during surgery by
rapid PTH testing. These two underwent immediate conventional exploration. In
one patient, a second adenoma was ultimately found inside a thyroid cyst; in the
other patient a smaller-than-anticipated adenoma had been removed during MIA,
whereas the second, larger adenoma that had been seen on imaging was located
more dorsally in the direct vicinity of the first lesion. Both explorations resulted in
persistent normocalcemia as well as normal serum PTH levels. The other two
cases in which surgery failed involved patients in whom single adenomas fitting
CHAPTER 4 I MINIMALLY INVASIVE ADENOMECTOMY
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Table 3 Results of surgical procedure after selection by preoperative US and CT
(group A).
Primary procedure Secondary procedure
n succ. (%) fail. succ. fail.
MIA* 51 49 (96) 2 2‡ -
CNE† 14 14 (100) - - -
*MIA= minimally invasive adenomectomy, †CNE= conventional neck exploration.
‡Both secondary procedures were done immediately.
Succ.= successful, fail.= failure.
Table 4 Perioperative outcome of preoperative imaging by combined ultrasound
and CT (group A).
MIA possible **
Preoperative advice yes no total
MIA* 49 2 51
CNE† 9 5 14
Total 58 7 65
*MIA= minimally invasive adenomectomy, †CNE= conventional neck exploration.
**Defined as a solitary adenoma at the predicted site surgically resectable through a minimal incision.
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the preoperative imaging results were removed during MIA, but hypercalcemia per-
sisted on follow-up. One of these patients underwent successful reexploration, dur-
ing which a second enlarged gland was retrieved. The other patient is awaiting
further surgical exploration. Conventional neck exploration failed in one patient as
a result of a missed third enlarged parathyroid gland in the thymus. As shown in
Table 6, ultrasound as the sole initial preoperative imaging modality in this series
resulted in a sensitivity of 76%, a specificity of 43%, and a positive predictive
value of 88%.
The overall success rate of MIA was 93% (96% in group A, 88% in group B). The
overall success rate for CNE was 96%.
32
Table 6 Perioperative outcome of preoperative imaging by ultrasound and selective
CT.
MIA possible **
Preoperative advice yes no total
MIA* 29 4 33
CNE† 9 3 12
Total 38 7 45
*MIA= minimally invasive adenomectomy, †CNE= conventional neck exploration.
** Defined as a solitary adenoma at the predicted site surgically resectable through a minimal incision.
Table 5 Results of surgical procedure after selection by preoperative ultrasound
and selective CT.
Primary procedure Secondary procedure
n succ. (%) fail. succ. fail. await.
MIA* 33 29 (88) 4 3 - 1
CNE† 12 11 (91) 1 1 - -
*MIA= minimally invasive adenomectomy, †CNE= conventional neck exploration.
succ.= successful, fail.= failure, await.= awaiting secondary exploration.
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Discussion
Our data confirm, once again, the high frequency (85-90%) of solitary adenomas
in patients with pHPT 1 2 3 4. Considering the number of successful MIA procedures
as a function of the total number of patients who undergo surgical treatment for
pHPT, CNE could be replaced by MIA in 71% of all patients (78/110): 75% of
patients in group A (49/65) and 64% of patients in group B (29/45). Clearly, these
figures justify the minimally invasive approach described here, which is character-
ized by a small incision in the skin directly over the affected parathyroid gland, as
marked by preoperative ultrasound. The technique uses anatomical planes to
reach the adenoma with virtually no unnecessary dissection. This is reflected by
the short duration of the procedure. However, experience in this type of surgery is
critical, because identification and retrieval of the enlarged gland through a mini-
incision are delicate procedures.
The advantages of MIA are clear. The principle of minimal dissection when possi-
ble and conversion to CNE if necessary poses the least possible risk of complica-
tions, including minimal risk to the recurrent nerve and the other (normal)
parathyroid glands. It also makes subsequent surgery in the (para)thyroid region
far less complicated than after CNE. Minimally invasive adenomectomy takes sig-
nificantly less time and is cosmetically attractive, and it could easily be performed
in a same-day surgery setting (and eventually under local anesthesia) in selected
patients.
Costs must be taken in consideration before any new approach can be definitely
evaluated, and the costs, including direct and indirect costs, of MIA versus CNE
are the subject of an ongoing study in our department. The additional costs of pre-
operative ultrasound and CT in every patient undergoing parathyroid surgery may
be neutralized by the much shorter operative time and by the shorter hospital stay,
with same-day surgery in selected patients. Intraoperative PTH measurment is not
specific to this new approach; rather, it should be used in every parathyroid surgi-
cal procedure to prevent persisting hyperparathyroidism and the subsequent need
for reoperation.
Although the failure rate of MIA is low (4% in this series) if the optimal imaging
strategy is routinely followed, one could argue that the procedure might not be as
effective as CNE in experienced hands. We believe, however, that MIA in similarly
experienced hands does not impose any undue risk for the patient, since the worst
outcome would still be a conventional exploration at a later stage, which is cur-
rently the standard operation for pHPT.
CHAPTER 4 I MINIMALLY INVASIVE ADENOMECTOMY
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The use of rapid PTH testing will undoubtedly make both the patient and the sur-
geon even more comfortable with the concept of MIA, because it allows direct con-
firmation of success 14 15 16. The surgeon can now be immediately aware of a failure,
should it occur, and may convert immediately to CNE to attain normocalcemia and
euparathyroidism. We have recently developed such a quick PTH-test and have
included it as a standard perioperative measure 10. Because this inexpensive test
requires approximately 40 minutes, we use the following protocol. Eight minutes
after adenomectomy, blood is taken for PTH-testing after which general anesthesia
is ended and the patient is brought to the recovery room. Only when the PTH test
has confirmed the MIA as successful is the patient allowed to leave the recovery
room. If the PTH results are unsatisfactory, the patient can be returned to the next
available operation room for subsequent CNE. This possibility is routinely dis-
cussed with the patient before surgery. The addition of routine perioperative PTH
measurement should result in a nearly 100% immediate success rate.
Our data show that the success rate of MIA depends on the imaging performed
before surgery. The sensitivity and specificity rates of combined US and CT (84
and 72%, respectively) are higher than those reported thus far for these modalities
7 8 17 18 19. This may be explained in part by the fact that we adhered strictly to a
combined imaging protocol in a prospective fashion, as opposed to the retrospec-
tive nature of most other investigations. The thorough discussion of each patient
by all members of the multidisciplinary team and the preoperative ultrasound-guid-
ed marking of the skin over the suspected adenoma also contributed to this dis-
crepancy.
In addition, the technological features of the ultrasound and CT devices played a
significant role. The use of CT imaging in cinevision mode (i.e., repeatedly going
up and down through the field of interest at the CT work station) is a major
advance in parathyroid imaging and a magnificent aid in preoperative planning.
In this series, initial imaging with ultrasound alone, followed by CT only if dictated
by the ultrasound findings, produced inferior accuracy compared with the com-
bined imaging strategy. This finding was contrary to our expectation but was in
concordance with other published data 3 8. Specifically, three of the four failures
occurred in patients who had undergone only ultrasound, suggesting that selection
for CT by ultrasound is less reliable. Most importantly, the presence of multinodu-
lar thyroid enlargement is a major obstacle for ultrasonographic examination 4.
Based on our results presented, we do not support the concept of routine ultra-
sound alone, followed by CT only in selected patients. In fact, once the data from
series B became available and turned out to be so much inferior to those of series
A, we returned to the standard preoperative regimen of both CT and ultrasound.
34
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Recent advances in radionuclide scintigraphy, including the use of
99mTechnetium-labeled sestamibi and other cationic complexes, have led to a
promising increase in preoperative localization of parathyroid adenomas, with
reported sensitivity rates of more than 85% 20 21. Probe-guided surgery has, there-
fore, been suggested to facilitate parathyroid exploration. This was recently shown
to be particularly true in the reoperative neck 22. Although the same group advocat-
ed radioguided surgery for primary parathyroid surgery as well 23, this was contra-
dicted in a recent report by Bonjer et al. 24.
Regardless of the imaging modalities advocated, several other investigators have
proposed less invasive strategies as alternative to CNE. Most have focussed on uni-
lateral neck exploration 5 14. Because this still requires the dissection of normal
parathyroids, such an approach will doubtlessly lack many of the advantages of
MIA. Chapuis et al. have described a truly minimally invasive technique, perform-
ing ultrasound-guided adenomectomy under local anesthesia 3. Although this was
feasible in only approximately 40% of their patients, we believe that in selected
patients direct adenomectomy as described in our study could eventually be car-
ried out under local anesthesia as well. This was recently confirmed by Norman
and Chheda 23, who used a direct approach under local anesthesia by reducing the
dissection field using nuclear scintigraphy and perioperative localization with a
hand-held probe. Alternatively, some surgeons have advocated endoscopy to per-
form a minimally invasive adenomectomy in selected patients 25. Although concep-
tually elegant, this technique appears difficult to learn and certainly requires more
operating time than the direct approach described here.
In conclusion, this study has shown that MIA is a safe and effective technique that
may be anticipated to replace CNE in approximately 75% of patients undergoing
surgical treatment of pHPT. Preoperative imaging should include a combination of
ultrasound and CT scanning, including the possibility of cinevision. Perioperative
measurement of PTH levels by rapid test methods will improve the surgical man-
agement of missed adenomas, permitting prompt CNE if MIA fails.
CHAPTER 4 I MINIMALLY INVASIVE ADENOMECTOMY
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The widespread use of multichannel serum chemistry autoanalyzers has resulted
in a sevenfold increase in the reported incidence of primary hyperparathyroidism
(pHPT) 1. Subsequently physicians have been increasingly confronted with the
most common form of pHPT: an asymptomatic or mildly symptomatic disease
characterized by mild chronic hypercalcemia with or without subtle symptoms
such as fatigue and muscular weakness. It is estimated that approximately 80% of
all the patients with pHPT fall into this category 2. Today it can be calculated that
pHPT develops in about 6000 patients each year in the Netherlands.
The serendipitous discovery of asymptomatic and mild pHPT has raised relevant
questions about the advisability of treatment in these patients. At the National
Institutes of Health (NIH) Consensus Development Conference on Diagnosis and
Management of Asymptomatic pHPT in 1990, surgical treatment was advised
along the guidelines given in Table 1 3. One could wonder however, why operative
treatment is not advised in more patients with pHPT, for surgery is the only cura-
tive treatment available, surgery is very successful (return to normocalcemia is
achieved in up to 95-99% of cases in experienced hands), surgery has a low mor-
bidity and even with a long follow-up the recurrence rate is very low 4.
Furthermore, after successful surgery the patient is saved repeated monitoring and
long term follow-up and there is no chance of developing one of the more severe
complications of hypercalcemia.
40
Table 1 Indications for surgical treatment in primary hyperparathyroidism according to
the National Institutes of Health Consensus Statement 1990.
Markedly elevated serum calcium: 2.85 to 3.00 mmol/L (normal range 2.20 to 2.60
mmol/L)
History of an episode of life-threatening hypercalcemia
Reduced creatinine clearance: reduced by 30% compared with age-matched normal
persons
Confirmed 24-hour urine calcium excretion > 10 mmol (normal range 2.5 to 7.5
mmol/24 hr)
Substantially reduced bone mass: more than two standard deviations below age-,
gender-, and race-matched controls
In addition:
Patient requests surgery
Consistent follow-up is unlikely
Coexistent illness complicates management
Patient is below the age of 50 years
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The standard operation for pHPT is a systematic bilateral neck exploration in
which all four parathyroid glands are sought and when identified, the macroscopi-
cally enlarged glands are removed. It is understandable that there is some reserva-
tion towards this surgical option. After all, there is a discrepancy between the
extent of the operation and incision versus the median size of the causative
parathyroid adenoma weighing in general no more then 200-300 mg. Although
surgical exploration is attended with a low morbidity, when complications do occur
they are serious. There is a small risk of permanent hypoparathyroidism (ranges
between virtually zero and four percent) and damage to the recurrent laryngeal
nerve leading to hoarseness and a reduced voice volume in less than one percent
of the cases 2. Also persistent hypercalcemia postoperatively, signaling a failure of
the operation, has to be considered as a complication 5.
It has to be realized that pHPT is a solitary gland disease in at least 85-90% of the
patients, meaning that in the majority of patients only one enlarged gland is caus-
ing the disease and consequently that removal of that one enlarged gland cures the
patient. Why then is an extensive bilateral neck exploration still the gold standard
when surgery is indicated ? The reason lies in the fact that preoperative localisato-
ry techniques have up till now not yielded satisfactory results in attempts to
replace the systematic bilateral neck exploration with a less extensive operation,
although unilateral operations have been advocated by some 6 7 8. The overall sensi-
tivity of techniques like ultrasonography (US), computed tomography (CT), mag-
netic resonance imaging (MRI), thallium-201/technetium-99m scintigraphy and
technetium-99m sestamibi imaging ranges from 40 to 90%, with specificity
reported from 65 to 95% (Table 2) 9. Ultrasonography is undoubtedly operator-
CHAPTER 5 I ASYMPTOMATIC AND MILDLY SYMPTOMATIC PATIENTS
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Table 2 Sensitivities and specificities of parathyroid imaging in patients without 
previous neck surgery.
sensitivity % specificity % references
Ultrasonography 34-92 75-96 9 11 12 17 18
Computed Tomography 41-86 62-94 9 11 12 18
Magnetic Resonance Imaging 57-90  75-91 9 12 17 18
Thallium 201/technetium-99m 
scintigraphy  25-74 68-93 9 11 12 17 18
Technetium-99m sestamibi 
iodine 123 imaging 60-88 97-100  19 20 21 22
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dependent whereas, not surprisingly, the sensitivity of all procedures declines
when the weight of the enlarged gland drops below 500 mg 9 10 11 12. These tech-
niques are also less accurate after previous neck surgery. Combining tests has
yielded somewhat better results: up to 87% using scintigraphy in combination
with US 8. The combination of three or more techniques has not increased the suc-
cess rate 10.
In general the results of preoperative imaging have not been good enough for a
substantial change in surgical policy. According to most authorities a bilateral neck
exploration is still the procedure of first choice when surgical treatment is indicated
4 13 14. In this respect one of the most cited remarks is that of the prominent
American radiologist Doppman ‘The only localizing modality required in the patient
who has not had any previous neck surgery is to localize an experienced parathy-
roid surgeon’.
So, seven years after the NIH consensus meeting, nothing much seems to have
changed. The indication to operate in patients with pHPT is, in the group fulfilling
the NIH criteria and/or suffering from major symptoms such as nefrolithiasis and
severe bone-pain, no matter of debate. For the majority of patients, that is the
group which is asymptomatic or only mildly symptomatic, most physicians under-
standably still prefer a conservative attitude.
However during these years changes have occurred as well in surgery as in radiol-
ogy and these changes might be relevant for patients with pHPT. The most promi-
nent change in surgery more recently has been the development and
implementation of minimally invasive techniques best exemplified by procedures
such as laparoscopic cholecystectomy and laparoscopic inguinal hernia repair. This
in turn has led more and more patients to request the least invasive technique pos-
sible, also in other areas of surgery. Progress in technology has greatly affected
radiological imaging. This improvement contributes considerably to the imaging
quality of the radiological techniques as US and CT, creating new possibilities for
more reliable localisatory procedures in pHPT.
Looking for a less invasive procedure in parathyroid surgery, encouraged by the
improvement of the radiological techniques and aware of the very high incidence
of solitary adenoma in pHPT, the subjoined hypothesis was born. If it would be
possible to localize the parathyroid adenoma preoperatively with high accuracy, an
adenomectomy by a local procedure instead of the conventional neck exploration
would be a potential option, resulting in less morbidity, reduction of operation and
admission time, and leaving a surgical scar of about 1.5 cm instead of at least 10
cm length.
Using Doppler assisted US and spiral CT for preoperative parathyroid imaging the
feasibility of a minimally invasive approach was tested by us originally in 15 symp-
tomatic patients 15. From the successful results it could be calculated that minimal-
ly invasive surgery would probably suffice in at least 70% of patients with pHPT,
42
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so that conventional neck exploration can be avoided. These good initial results
were further corroborated in a subsequent large prospective evaluation study
including all consecutive patients who presented with an indication for operative
treatment 16. This series again proved the correctness of the original hypothesis. A
total of 66 patients (54 female, 12 male) with a median age of 60 years and a
median serum calcium of 2.90 mmol/L (2.55-3.60) were studied. Fifty-one of
these patients underwent a minimally invasive approach which was successful in
49. In two patients conversion to a conventional neck exploration -in the same
operative session- was necessary. A conventional neck exploration was primarily
carried out in the other 15 patients because of equivocal results of preoperative
imaging. The median operation time in the minimally invasive group was 15 min-
utes (10-35), that in the group which underwent the conventional neck explo-
ration was 75 minutes (60-120). All 66 patients became normocalcemic
postoperatively. Except for one patient who suffered a transient unilateral vocal
cord paralysis no complications were registered. Overall the combination of preop-
erative Doppler US and spiral CT-scanning made a successful minimally invasive
approach of pHPT possible in 74% (49/66) of patients.
The data presented above leave us in no doubt that minimally invasive surgery
definitively has entered the treatment of pHPT. This certainly applies to the
patients with symptomatic disease, but it could well have consequences also for
the large group of patients with asymptomatic or only mildly symptomatic pHPT.
Suppose a patient with asymptomatic or only mildly symptomatic pHPT undergoes
parathyroid imaging, preferably by US and CT (based on our personal favourable
experience), and imaging shows a definite adenoma suited for the minimally inva-
sive approach then this patient could be definitively cured by a small operation
and with a low chance of recurrence of disease this obviates the need for frequent
out-patient follow-up, and for repeated blood testing and prevents any anxiety that
symptoms will occur or will worsen.
In other words, experience with the minimally invasive approach of pHPT in symp-
tomatic patients has given us new arguments for the surgical option in asympto-
matic or mildly symptomatic pHPT patients. We therefore tentatively propose a
new strategy. If a patient presents with a biochemically proven asymptomatic or
mildly symptomatic pHPT decision-making according to the following algorithm is
advised (Table 3). Localization of the enlarged gland should be attempted by
means of doppler US and spiral CT. The examinations should be performed sys-
tematically under guidance of a dedicated radiologist and the results discussed
with the surgeon in charge. When the test results unequivocally indicate a solitary
adenoma the patient is advised to undergo a minimally invasive procedure. When
the test results are equivocal or indicate the possibility of multiglandular disease a
conservative policy is advocated. When the disease should progress in time or the
patient develops major symptoms and/or fulfils the NIH-guidelines, parathyroid
CHAPTER 5 I ASYMPTOMATIC AND MILDLY SYMPTOMATIC PATIENTS
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imaging procedures should be repeated preceding the then indicated operative
treatment.
Implementation of such a strategy could be of considerable benefit to a substantial
number of patients with asymptomatic or only mildly symptomatic primary hyper-
parathyroidism.
44
Table 3 Algorithm in asymptomatic/mildly symptomatic pHPT.
pHPT primary hyperparathyroidism
US doppler assisted ultrasonography
CT spiral computed tomography
MIS minimally invasive surgery
CNE conventional neck exploration
*progressive disease is defined as the development of signs according the NIH-criteria which were
previously absent and/or the development of major symptoms.
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Abstract
Purpose To determine the role of ultrasound (US) with supplemental computed
tomography (CT) in patients with primary hyperparathyroidism (pHPT) to undergo
minimally invasive surgery (MIS) instead of conventional neck exploration.
Materials and methods US and CT were performed in 61 consecutive patients with
pHPT (part I) to identify and localize solitary adenomas for resection by MIS and to
provide a surgical roadmap. In part II, involving 33 consecutive patients, CT was
performed only when no solitary adenoma was identified with US, or for roadmap
information. MIS was considered successful when serum calcium levels normal-
ized and remained stable.
Results In part I, 46 definite solitary adenomas were found by US and two addition-
al ones by CT. MIS was successful in 45 patients and failed once. In part II, US
identified 23 solitary adenomas and CT found one. MIS was successful in 22
patients and failed in two. Combined results of 94 patients demonstrated success-
ful MIS in 67 (71%), with 64 of them selected by US alone (95% CI: 61-80).The
sensitivity of US in diagnosing solitary adenomas was 78% (95% CI: 67-86) with
a positive predictive value of 96% (95% CI: 88-99).
Conclusion US evaluation of patients with pHPT allowed successful selection for
MIS in more than two thirds of cases, with additional CT being chiefly useful for
surgical road-mapping.
48
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Introduction
Primary hyperparathyroidism (pHPT) is a relatively uncommon disease in adults
with an estimated prevalence of 1 : 700 in the United States 1. Women, particular-
ly postmenopausal, are affected 2 to 3 times more frequently than men 2. Clinical
manifestations of pHPT include renal calculi, gastric ulcers, bone cysts and mental
depression. Its diagnosis is based on elevated serum calcium and parathyroid hor-
mone levels. In the vast majority (approximately 85%) of patients, a solitary
parathyroid adenoma is the cause of the disease 3 4 5. Multiglandular involvement,
either caused by multiple adenomas (4%) or diffuse hyperplasia (10%), is much
less common 4. Rare causes of pHPT are parathyroid cyst and carcinoma.
The common treatment of pHPT is conventional neck exploration (CNE) 6. With
this procedure, the neck is explored in order to identify all parathyroid glands and
to remove the enlarged ones. CNE is a time consuming and surgically demanding
procedure because of the many vulnerable structures of the neck that need to be
explored to allow identification of the parathyroid glands. Nevertheless, in experi-
enced hands, CNE is curative in 95% of cases with few reported complications 6 7 8.
Recently, we introduced minimally invasive surgery (MIS) by use of US and CT
imaging to treat patients in whom the disease is caused by a solitary adenoma, and
in this earlier report, which included 61 patients of the current study, we highlight-
ed the clinical aspects of this method 9. During the MIS procedure, the surgeon,
guided by an imaging-based roadmap, carefully approaches the lesion through a
small incision in the skin and removes it with minimal damage to the vulnerable
structures of the neck. Advantages of MIS compared to CNE include reduction in
operation time and hospital stay with subsequent decreased costs, improved cos-
metic results, and restriction of postoperative fibrosis to the immediate area of the
removed gland, facilitating re-operation in case of recurrence of disease 10.
The typical adenoma is small, usually not palpable because its consistency is
equal to that of fat, and is often hidden among the structures of the neck.
Consequently, a high accuracy is required in diagnosing and localizing the solitary
lesion. In addition, accurate determination of its relationship with the surrounding
structures is needed in order to perform MIS successfully.
The purpose of the current study was to investigate prospectively the role of ultra-
sonography (US) as the primary imaging modality for identification and localization
of parathyroid adenomas in patients with pHPT to undergo MIS. As the surgical
technique was relatively new when we initiated this study and we were uncertain
about the full potential of US in facilitating the surgery, we used computed tomog-
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raphy (CT) as a supplemental test to increase confidence in lesion diagnosis and to
provide an operator-independent roadmap for the surgeon.
Materials and methods
Overall design
The study population consisted of consecutive patients admitted to our institution
who were scheduled for surgical treatment of clinically proven pHPT, i.e. a blood
serum parathyroid hormone level higher than 8 pmol/L and/or a serum calcium
level higher than 2.60 mmol/L. Ninety-four patients with pHPT were enrolled, 21
of them were men and 73 women, with a mean age of 58 (range 17-84). The
median serum calcium level was 2.82 mmol/L (normal 2.20-2.60 mmol/L; range
2.42-3.60 mmol/L), the median serum parathormone was 12.2 pmol/L (normal
<8 pmol/L in normocalcemic state; range 4.9-234.0 pmol/L). One or more mani-
festations of the disease were present in 40 (43%) patients; 21 had renal stones,
20 suffered from malaise/fatigue and 10 patients from bone/joint pain.
Two distinct diagnostic strategies were followed. In the first (part I, 61 patients),
performed from October 1994 through April 1997, all patients underwent both US
and CT imaging of the neck. In the second (part II, 33 patients), performed from
May 1997 through April 1998, all patients underwent US, and supplemental CT
was performed only when no solitary adenoma was identified by US or when
requested by the surgeon for additional road-mapping. Eighty-nine of the 94 US
examinations were performed and interpreted by one radiologist (AvD). This radiol-
ogist also interpreted the US findings of the remaining five patients whose exami-
nations were performed by an experienced sonographer. In all cases the US
findings were interpreted without knowledge of any prior imaging studies, if pres-
ent. All CT images were interpreted by the same radiologist with knowledge of the
US findings, and the final diagnosis was based on the combined results. When the
final preoperative diagnosis of a definite solitary adenoma was made, the patient
was scheduled for MIS, and in all other cases CNE was performed. The study was
approved by the Institutional Review Board, and informed patient consent was
obtained in all cases. All patients who were scheduled for MIS had a repeat US
examination immediately prior to the operation with the neck extended in the posi-
tion in which surgery was going to be performed. The previously diagnosed solitary
adenoma was then localized again in the presence of the surgeon, the surgical
approach assessed and the optimal incision site marked on the skin of the patient.
50
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Ultrasound imaging
The equipment used were real time units with 4-7 mHz and 5-10 mHz transduc-
ers (HDI 900 and 3000, Advanced Technical Laboratories, Bothel WA, USA).
Examination was performed with the patient in supine position and the neck
extended. The area from the carotid bifurcation to the deepest accessible part of
the mediastinum was scanned in longitudinal and transverse planes. Graded com-
pression was used to improve visualization of the deep paratracheal and para-
esophageal areas, and, in case of doubt, to differentiate between an intra- or
extrathyroidal location of a lesion. When a possible parathyroid lesion was identi-
fied, color-Doppler was applied to determine the presence of vascularity of the
lesion and/or to identify a vascular pedicle favoring the diagnosis of a parathyroid
adenoma. Lesion mobility during swallowing and/or deep breathing was also
observed to allow differentiation from structures such as para-carotid cervical
lymph nodes or the longus colli muscle. The thyroid gland was also evaluated and
assessed for the presence of disease. The initial US examination required approxi-
mately 15 minutes and the preoperative repeat examination about 5 minutes.
Spiral Computed Tomography imaging
Contrast-enhanced CT scanning was performed with the patient in supine position
and the neck in slight extension with the shoulders pulled down as much as possi-
ble. Ninety mL of non-ionic contrast medium (Isovist, Schering M, Berlin,
Germany) were given intravenously with a rate of 2 mL/sec. Imaging was initiated
25 sec. after the beginning of the administration of the contrast medium. In a sin-
gle breath-hold the volume from the level of the mandibular angle to that of the
aortic root was scanned. A table speed of 5 mm/sec. and a slice thickness of 5
mm with a gantry rotation time of 1 sec. were applied with a reconstruction index
of 3 mm. The obtained images were evaluated on hard copy and in cine loop using
a dedicated computer workstation (EasyVision workstation; Release 2.1, Philips
Medical Systems, Best, The Netherlands).
Grading of adenomas by Ultrasound and Computed Tomography
Ultrasound: The normal parathyroid glands are oval or bean-shaped and measure
on average 6 mm in length with a mean weight of 40 mg. They contain a consid-
erable amount of stromal fat 11 and are generally not visualized with current US
equipment 12. The US diagnosis of a typical ‘definite’ adenoma was made when a
lesion was visualized with a homogeneous hypo-echoic reflection pattern relative
to thyroid tissue (Figure 1) and showing the following characteristics. Typically, the
shape varied from round/oval to elongated with an alignment in a craniocaudad
orientation and a diameter of at least of 8 mm when round or up to 3 cm long
when elongated 5 13 14 15. In addition, the typical adenoma was located closely to the
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thyroid gland, or more caudad in the paratracheal or para-esophageal space.
Essential for the diagnosis of a parathyroid adenoma was that the lesion retained
its relationship with the thyroid gland during swallowing and deep breathing and
did not show a central hilum.
Furthermore, any oval, elongated or lobulated lesion in the same location and with
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Figure 1 Patient with a solitary adenoma, superior type.
(a) Transverse US image of the neck demonstrating the adenoma (between arrows) as a
hypoechoic lesion behind the right thyroid lobe, allowing the diagnosis of a definite ade-
noma. The surgical approach is drawn with a dotted line.
(b) Longitudinal US image showing the adenoma as an elongated mass (between arrows)
located behind the thyroid, consistent with a ‘superior type’ adenoma.
(c) Transverse CT image of the neck at the same anatomic level as figure 1a showing the
adenoma (between arrows) and surrounding structures. The surgical approach is drawn
with dotted line.
(d) Surgical specimen of the adenoma. Weight 705 mg.
Note: T = thyroid, Tr = trachea, C = carotid artery, V = vertebral body, E = esophagus,
stc.m = sternocleidomastoid muscle, str.m strap muscles.
a b
c d
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the same mobility, but with an increased and/or irregular reflection pattern, cystic
changes (Figure 2) and/or calcifications representing degeneration 13 14 and meas-
uring from 1-2 cm to approximately 5 cm in length, was also considered a definite
adenoma. A subcapsular, intrathyroidal lesion with the characteristics of a parathy-
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Figure 2 Patient with a solitary adenoma, inferior type.
(a) Transverse US image demonstrating the adenoma as an oval echogenic lesion (arrows)
with small cystic changes (arrow heads). The surgical approach is drawn with dotted line.
(b) Transverse CT image corresponding to figure 2a demonstrating the adenoma (arrows)
and the surgical approach (dotted line).
(c) Longitudinal US section showing that the adenoma (arrows) is located just caudad to
the thyroid gland and close to the strap muscles, corresponding with an ‘inferior-type’
adenoma. Few small cysts (arrow heads) are present.
(d) Surgical specimen of the adenoma demonstrating the multiple small cysts (arrow
heads). Weight 1287 mg.
Note: T = thyroid, Tr = trachea, C = carotid artery, V = vertebral body, E = esophagus,
stc.m = sternocleidomastoid muscle, str.m strap muscles.
a b
c d
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roid adenoma was considered a definite parathyroid adenoma when the thyroid
was otherwise normal and when there was no evidence of an adenoma elsewhere.
A poorly visualized lesion with localization and movement at swallowing suggestive
of adenoma was also considered a definite adenoma when the lesion showed clear
vascularity by color Doppler (Figure 3).
A lesion was considered an ‘equivocal’ adenoma in case its characteristics did not
completely fulfill the criteria given above. A lesion was diagnosed as no adenoma
when its mobility during swallowing was not related to that of the thyroid unless
an aberrant location e.g. in the carotid sheath was considered or when an evident
central hilum was visualized and also the shape, size and reflection pattern were
compatible with a lymph node. A patient was considered to have a definite ‘soli-
tary’ adenoma when a definite adenoma as described earlier was the only identi-
fied lesion. In all other instances, i.e. when an equivocal solitary lesion, definite or
equivocal multiple lesions, or no lesions were found, the diagnosis of ‘no definite
solitary adenoma’ was made. When the solitary adenoma was located posterior to
the thyroid lobe near the mid portion, it was called a ‘superior type’ adenoma
(Figure 1). It was called an ‘inferior type’ when it was located near the lower pole
of a thyroid lobe or inferior to it and having, at least in part, a close relationship
with the anterior muscular wall of the neck (Figure 2). Any other location was con-
sidered ‘aberrant’.
Computed Tomography: The images were analyzed with knowledge of US findings. In
a case of a definite adenoma by US the diagnosis was not changed when the CT and
US findings were compatible; otherwise the final diagnosis was equivocal adenoma.
Criteria were that either the adenoma was visualized by CT as a contrast-enhancing
lesion in the same location and with the same size as seen with US or, in case of a
close relationship with the thyroid gland by US, the lesion was only recognized as a
local bulge of the contour of the thyroid at the same location as seen with US.
When a lesion was diagnosed by US as an equivocal adenoma because of poor
visualization, it was considered a definite adenoma when it was visualized by CT
as a contrast enhancing lesion in the same location and with the same size as
seen with US. In case of a lesion, well visualized by US but diagnosed as an equiv-
ocal adenoma because it did not fulfill the other criteria as described earlier, the
US diagnosis was not changed by the CT findings.
When by CT an enhancing lesion with the size and location compatible with a
parathyroid adenoma was found which was not visualized by US, it was consid-
ered a definite adenoma only if it was located in an area not well accessible to US
examination, such as the deep para-esophageal and mediastinal regions; other-
wise the lesion was considered an equivocal adenoma.
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Surgical procedure, histopathology and follow-up
Guided by the imaging-based ‘road map’, MIS was begun with a 2-cm, transverse
incision at the medial border of the sternocleidomastoid muscle at the site of the
skin marking. After lateral mobilization of the muscle, internal jugular vein and
common carotid artery and medial mobilization of the strap muscles and thyroid
gland, the tracheo-esophageal groove was entered and the enlarged gland was
identified and removed (Figure 1). If during MIS no lesion could be identified, the
surgery was converted to CNE. Surgery was qualified as successful when the
serum calcium levels normalized within 24 hours and remained stable for at least
6 months. The surgical specimens were weighted in the pathology department,
and histopathological examination was performed by the pathologist to assess the
presence of parathyroid tissue. The lesions were considered to represent adenoma
when at histological evaluation parathyroid tissue was found. Histological differen-
tiation between adenoma and hyperplasia was not made in our institution 16.
Statistical analysis
The data were analyzed statistically using two different approaches. The first
analyses were performed while considering the patients as the units of analysis.
As only definite solitary adenomas were considered eligible for MIS, the imaging
results were categorized as patients with the preoperative diagnosis ‘solitary ade-
noma’ or ‘no solitary adenoma’. In other words, the imaging was used as a screen-
ing test yielding either ‘solitary adenoma - eligible for MIS’ or ‘no solitary adenoma
- not eligible for MIS’. To obtain sensitivity, specificity and predictive values of this
screening test, a gold standard test indicating whether a patient in reality was suit-
able for MIS, is required. In this study, the latter can only be established with con-
fidence after surgery and follow-up. Therefore, the final diagnosis serves as the
gold standard in this study. The final diagnosis was made on the basis of the find-
ings during surgery combined with the course of post-surgical serum calcium lev-
els. If at surgery a single adenoma was removed and calcium levels normalized
and remained stable as described earlier, the final diagnosis was ‘solitary adeno-
ma’. In all other cases, the final diagnosis was ‘no solitary adenoma’. Using this
approach, sensitivity of US denotes, among patients with a final diagnosis of soli-
tary adenoma, the probability of a US diagnosis of a solitary adenoma at the same
location as observed at surgery. The positive predictive value of US denotes,
among patients with a solitary adenoma on US, the probability of a final diagnosis
of solitary adenoma at the predicted location. The negative predictive value
denotes, among patients with no solitary adenoma on US, the probability of a final
diagnosis of no solitary adenoma. Specificity denotes, among patients with a final
diagnosis of no solitary adenoma, the probability of no solitary adenoma on US. All
probabilities from this analysis are presented as percentages with exact binomial
95% confidence intervals 17.
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Figure 3 Patient with a solitary adenoma, superior type.
(a) Transverse US section shows ill-defined hypoechoic lesion (arrows) behind the right thy-
roid gland indicative of an ‘equivocal’ adenoma.
(b) Longitudinal section demonstrates again poor visualization of the lesion (arrows) which
is compressed between thyroid and cervical spine.
(c) Transverse color Doppler US image at the same level as figure 3a showing extensive
vascularization of the lesion, allowing diagnosis of a ‘definite’ adenoma.
(d) Transverse CT section showing the adenoma only as enlargement of the posterior aspect
of the right thyroid lobe (arrow), due to its close relation to the thyroid and the identical
enhancement.
Note: T = thyroid, Tr = trachea, C = carotid artery, V = vertebral body, E = esophagus.
a b
c d
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Figure 4 Patient with incorrectly diagnosed solitary adenoma.
(a) Transverse US image at level caudad to thyroid gland shows a moderately echogenic
lesion (arrows) between the right carotid artery and the anterior muscular wall of the
neck. The lesion was believed to be a solitary parathyroid adenoma.
(b) Transverse CT image at same level as 4a showing the same lesion (arrows), which was
removed by MIS. Histopathologic examination of the specimen revealed only thyroid tissue.
(c) Transverse US section of the neck showing the solitary parathyroid adenoma found at
subsequent CNE. The lesion is located subcapsularly in the thyroid gland and was
believed to be a thyroid nodule at initial US examination. Doppler US shows the pres-
ence of a vascular pedicle (arrows).
(d) Longitudinal US section of the adenoma showing the oval shape but with rather sharp
edges probably caused by the subcapsular position. In retrospect, these edges favor the
diagnosis of a parathyroid adenoma above a thyroid nodule.
Note: T = thyroid, Tr = trachea, C = carotid artery, stc.m = sternocleidomastoid mus-
cle, str.m strap muscles.
a b
c d
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Second, we carried out analyses with adenomas as units of analysis. Because in
this situation the number of no solitary adenoma diagnoses (both on ultrasound
and at surgery) is undefined, only sensitivity and positive predictive value were cal-
culated. Using this approach, the sensitivity denotes the probability that an adeno-
ma found at surgery had also been identified at that site by US, and the positive
predictive value is defined as the probability that an adenoma identified by ultra-
sound was present at surgery at the same location. As in this analysis the observa-
tions may not be independent within patients, confidence limits were omitted.
Results
The results of US, CT and surgery evaluation for both series are given in Table 1.
In part I there were 61 patients; in 46 of those a definite solitary adenoma was
diagnosed by US and the diagnosis was not changed by CT. In the remaining 15,
CT changed the US diagnosis to a definite solitary adenoma in two cases. In one of
them, CT changed the initial US diagnosis of equivocal to a definite solitary adeno-
ma. In the other one, in whom no lesion was seen by US, CT identified a solitary
adenoma in a deep paratracheal/mediastinal location (this lesion was later visual-
ized, with knowledge of the CT findings, on the repeat US examination performed
immediately before surgery). Thus, in part I there were 48 patients with the final
diagnosis of a definite solitary adenoma. All underwent MIS except for one patient
who underwent primary CNE because the MIS procedure was considered surgical-
ly impossible due to the presence of extensive multinodular goiter and resulting
deep location of the lesion demonstrated by imaging. Of the 47 patients undergo-
ing MIS, surgery was converted to CNE in one because during MIS the lesion could
not be found due to extensive fibrosis in the operation area caused by prior thy-
roiditis. In the remaining 46, MIS was completed without surgical complications.
Serum calcium levels normalized in 45 of these, resulting in a 98% success rate of
the MIS procedure. Calcium levels did not normalize in one of the 46 patients, and
histological examination of the specimen in this case revealed normal thyroid tis-
sue without parathyroid components. In retrospect, the lesion that was diagnosed
as a definite solitary adenoma by US and confirmed by CT, appeared to be an
accessory thyroid gland, located two cm inferior to the right thyroid lobe (Figure
4a,b). CNE performed two days later revealed a small (274 mg) intrathyroidal
parathyroid adenoma located subcapsular in the left lobe (Figure 4c,d). In another
patient undergoing successful MIS, the visualized lesion proved to consist of two
abutting adenomas rather than one solitary lesion, and the final postoperative
diagnosis in this case was therefore multiple adenomas.
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Table 1
 R
esults of part I (n=
6
1
), part II (n=
3
3
) and com
bined results (n=
9
4
): Im
aging diagnosis, type of surgery, failures and final findings.
Im
aging D
iagnosis 
Type Surgery 
Failures 
Final findings
U
S 
com
bined 
M
IS 
prim
ary C
N
E 
solitary 
no solitary 
U
S and C
T
(m
ultiple)
Part I
D
efinite solitary adenom
a 
4
6
4
8
 
4
6
+
1
* 
1
 
1
 
4
7
 
1
N
o definite solitary adenom
a 
1
5
 
1
3
- 
1
3
 
- 
9
 
4
Total (patients) 
6
1
 
6
1
 
4
6
+
1
* 
1
4
 
1
 
5
6
 
5
Part II
D
efinite solitary adenom
a 
2
3
 
2
4
 
2
4
 
0
 
2
 
2
3
 
1
N
o definite solitary adenom
a 
1
0
 
9
- 
9
 
1
 
6
 
3
Total (patients) 
3
3
 
3
3
 
2
4
 
9
 
3
 
2
9
 
4
C
om
bined results
D
efinite solitary adenom
a 
6
9
 
7
2
 
7
1
 
1
 
3
 
7
0
 
2
N
o definite solitary adenom
a 
2
5
 
2
2
 
- 
2
2
 
1
 
1
5
 
7
Total (patients) 
9
4
 
9
4
 
7
0
+
1
* 
2
3
 
4
 
8
5
 
9
 
* C
onverted to C
N
E.
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In part II there were 33 patients. In 23 of these a definite solitary lesion was diag-
nosed by US and they were directly scheduled for MIS. In the remaining 10, CT
was subsequently performed which identified only one additional solitary adenoma
in a deep para-esophageal location. Thus, in this series there were 24 patients
with a solitary adenoma who all underwent primary MIS. In no case the operation
was converted to CNE, and in all the removed lesion proved to contain parathyroid
tissue at histopathological examination. In two of the 24 patients, however, serum
calcium levels did not normalize following MIS. On subsequent CNE, a large (900
mg) second adenoma was found in one patient at the same location at which ini-
tially a small (230 mg) adenoma was removed during MIS. In this case only the
large adenoma had been identified by imaging. In the other one, CNE revealed a
large part of an adenoma at the same location where during prior MIS fragments of
an adenoma were removed with total weight of 1,020 mg. In this case a much
larger lesion (44x22x11 mm with estimated weight of 6,000 mg) had been diag-
nosed by the initial US. Thus, 22 of the 24 MIS procedures were successful result-
ing in a 92% success rate. In 6 of the 23 cases additional CT was performed at
request of the surgeons, particularly by one who was new on the team and who
had therefore less experience with the US-guided MIS procedure. In these patients,
the CT scans were used exclusively for road-mapping in case of a deep para-
esophageal location of the adenoma by US 3, severe enlargement of the thyroid
due to goiter (2), or when there was an extremely large parathyroid adenoma diag-
nosed by US (n=1, weight of the specimen 16.010 mg). However, in these cases
CT findings were not used for lesion diagnosis.
In part I and II combined, 69 definite solitary adenomas were diagnosed by US, in
three of these the diagnosis was incorrect. Of the 66 solitary adenomas correctly
diagnosed by US, 34 were in a ‘superior’ location, 27 were ‘inferior’ and 5 had an
‘aberrant’ location (intrathyroidal (n=1), para-esophageal (n=3) and cranial to the
thyroid (n=1).
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Histopathological results
At histopathological examination parathyroid tissue was identified in all 107 surgi-
cal specimens with exception of one, where only normal thyroid tissue was found. The
median weight of the parathyroid specimens was 610 mg (range 90 -16,020 mg).
Statistical results
The results of the combined parts I and II in selecting patients with a solitary ade-
noma by US for MIS are depicted in Table 2. In total, there were 85 (90%)
patients with a solitary adenoma according to the gold standard, i.e. the final oper-
ative results and change of the serum calcium levels. The sensitivity of US for diag-
nosing and localizing solitary parathyroid adenomas was 78% (66/85; 95%CI:
67-86) and the specificity also 78% (7/9; 95%CI: 40-97). The positive predictive
value was 96% (66/69; 95%CI: 88-99) and the negative predictive value 28%
(7/25; 95%CI: 12-49). In two of the three false positive cases there was
multiglandular disease as described before, and in one there was a solitary adeno-
ma which was not located at the predicted site.
In total, there were 106 adenomas in the 94 patients (85 with a solitary adeno-
ma, and 21 adenomas in 9 patients with multiple lesions). The sensitivity of US
for correctly diagnosing and localizing parathyroid adenomas was 74% (78/106);
the positive predictive value was 98% (78/80). A false positive diagnosis of an
adenoma was made in two patients. In one, the imaging-identified lesion proved to
be aberrant thyroid tissue, and in the other, a small (8x7x3 mm) lesion identified
by US, was not found at surgery.
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Table 2 Results of US in correctly finding patients with a solitary parathyroid adenoma
(part I and II combined).
Results surgery Total
Results US present not present
Solitary adenoma 66 2+1* 69
No solitary adenoma 18 7 25
Total 84 9+1* 94
* one present, but not at predicted location.
Sensitivity 66/(84+1*) 78%
Positive predictive value 66/69 96%
Specificity 7/9 78%
Negative predictive value 7/25 28%
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Discussion
The results of the first series of 61 patients with pHPT (part I) made it clear that,
in more than two thirds (77%) of patients, successful MIS could be performed
using the combined US-CT preoperative evaluation. In this series CT played only a
limited role as additional diagnostic imaging modality, as there was no change in
diagnosis in any of the 46 (75%) patients who harbored a definite US-diagnosed
solitary adenoma, and it identified only two additional patients with such a lesion.
These findings, combined with the increased confidence of the surgeon in the role
of US, made us decide to initiate the second part of the study, in which CT was only
used selectively. In this series (part II), CT only added one additional case for MIS.
The combined results of part I and II demonstrate that US is an excellent tool for
selecting those patients with pHPT in whom successful MIS can be performed. In
the 70 completed MIS procedures, three cases were selected by CT and thus 67
by US alone. Three of the 70 MIS procedures were unsuccessful, resulting in a
96% (67/70) success rate of the surgical procedure. This success rate for MIS is
similar to that reported for primary CNE performed by experienced surgeons in
patients who did not undergo preoperative imaging 6 7 8. Thus, considering the
results of the entire group of 94 patients, preoperative imaging was of major bene-
fit to more than two thirds (71%) of our patients because they were able to under-
go a limited, but equally successful operation for treatment of their pHPT instead
of an extensive, complicated conventional surgical procedure.
It is well recognized, in case of ectopic adenomas with mediastinal or deep para-
tracheal and/or para-esophageal location, that US is of limited value because the
lesions are generally inaccessible to the US beam; however, in these cases, they
are usually well visualized by CT 3 5 13 14 18. Nevertheless, in selecting patients for
MIS, the added value of CT scanning was limited in our study because it identified
only three additional definite solitary adenomas out of the entire group of 25
patients with ‘no solitary adenoma’ diagnosed by US. In two of these, the adeno-
ma was located deeply in an area inaccessible to US, and in one the diagnosis of
an equivocal lesion was changed to a definite solitary adenoma. Although in both
cases of deep localization the adenoma was visualized at repeat US with knowl-
edge of the CT findings, it is conceivable that visualization may be impossible at
repeat US. In such a situation MIS could still be considered; however, the deep
location of the lesion and the absence of preoperative localization of the adenoma
and determination of the optimal incision site may make a surgical approach
through a small opening in the skin very difficult, if not impossible.
In our study we used CT exclusively as an adjunctive test and we did not evaluate
its role as primary imaging tool. However, in our experience, application of spiral
62
06. hoofdstuk 06  23-07-2001  10:15  Pagina 62
CT with cine loop presentation of images allows easy identification of a number of
lesions and provides an excellent display of the visualized adenoma in its sur-
rounding anatomical structures. Therefore, CT could potentially also be used as the
primary test for selecting patients for MIS. However, the cost of CT is generally
much higher than that of US, and the modality involves the use of ionizing radia-
tion to a vulnerable area (thyroid gland) with associated risks 19. For these reasons
together with its good results we prefer to use US as the primary modality for
selection of the patients for MIS. Nevertheless, in selected cases the surgeon may
still want to have an additional CT for road mapping, as has been our experience,
particularly in cases when the lesion is located deeply, or when the thyroid gland is
enlarged.
Magnetic resonance (MR) imaging and scintigraphy have also been used for identi-
fication of parathyroid adenomas with results comparable to those of US and CT 4
20. In our study we preferred to use CT as additional modality over MR imaging for
reasons of availability and costs, and therefore the role of this modality in selecting
patients for MIS was not determined. Conventional scintigraphy is, in our opinion,
not well suited for selecting patients for our MIS procedure because of the relative-
ly poor image resolution and anatomical information obtained. Recent studies have
shown, however, that a minimally invasive surgical procedure is possible in cases
where the uptake of the administered radiopharmacon is sufficient to allow local-
ization of the parathyroid adenoma intra-operatively with a small gamma probe 21 22.
In one patient with two, contiguous adenomas simulating one lesion by imaging,
MIS was successfully performed because during the surgery a discrepancy was
noted between the size of the lesion that was first removed and the size predicted
by imaging. Technically, MIS allows removal of multiple lesions through the same
incision; however, since in case of multiglandular disease all parathyroid glands
may be involved and identification by US is less successful due to the small aver-
age size of the enlarged glands 13, it is important that all glands be surgically
inspected. Therefore we prefer to perform CNE in case enlargement of more than
one gland has been diagnosed.
In three patients MIS was unsuccessful. One of these treatment failures was
caused by an incorrect imaging diagnosis, in which an accessory thyroid gland was
misinterpreted as being a parathyroid adenoma. In another case, there were two
adenomas close to each other in the same anatomical location, and only the
largest was visualized by preoperative imaging. However, in this case the MIS pro-
cedure was terminated after removal of the smaller one because no notice was
made of the discrepancy between the size of the removed adenoma and that of the
larger one visualized by US and found later at CNE. In the third case, the surgeon
removed initially only a part of the predicted large adenoma and the remainder
was left behind, which was later removed at CNE. These experiences emphasize
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the importance to correlate during MIS the size of the removed adenoma with the
size predicted by imaging. Application of a test that allows rapid determination of
the parathyroid hormone level in the blood at the end of the surgical procedure
may also alert the surgeon to incomplete resection or the presence of a second
adenoma in case the hormone level remains elevated. Such a test, which takes
only 40 minutes to complete, was recently introduced at our institution as a rou-
tine procedure, allowing to perform re-operation within an hour in case of initial
failure 23.
US showed an overall sensitivity in identifying parathyroid adenomas of 74% (soli-
tary and multiple adenomas combined). Although we considered in our conserva-
tive approach all equivocal adenomas as ‘negative’ findings, these results are
within the range (65%-85%) of those reported by others in identifying parathyroid
adenomas with US imaging 13 15 18 20 24. However, our positive predictive value of
98% in diagnosing parathyroid adenomas, and thus the nature of the lesions, by
US was high compared to that of others (range 80%-97%) 13 15 18 20 24. Because of
the high accuracy in determining the nature of the lesions, we were also able to
diagnose solitary parathyroid adenomas with high consistency (predictive value of
96%), something that is of crucial importance for successful MIS. In our study less
then 10% of the patients had multiglandular disease, supporting the suggestion by
some authors 25 that the true frequency of multiglandular involvement is lower than
the 15% that is usually reported 3 4 5.
In our experience, characterizing the location of the solitary adenomas as ‘superi-
or’, ‘inferior’ or ‘aberrant’ was very useful in the communication with the surgeon
because it gave essential information about the anatomical localization of the
lesion with its surrounding structures, needed for the implementation of the MIS
procedure. Our approach to diagnosing a definite solitary adenoma was rather con-
servative to minimize the number of unsuccessful MIS procedures. Whether a defi-
nite adenoma was diagnosed or not, in all patients with the presentation of one or
more equivocal lesions, primary CNE was performed. If we had considered the
equivocal lesions to be all ‘definite’ adenomas or all ‘negative’, in both instances
we would have been able to perform more successful MIS procedures; however,
this would have been at the expense of substantially more surgical failures.
A limitation of our study is that the patient groups were taken as convenience sam-
ples (group I came before group II). As a result, temporal effects on the results
cannot be excluded. For instance, in group II the clinicians could have been more
familiar with the advantages of MIS compared to CNE. They may therefore have
lowered their threshold by referring patients with minimal or no clinical symptoms
of pHPT for group II of the study. Such patients are more likely to harbor relatively
small adenomas which are more difficult to diagnose and operate upon. On the
other hand, learning effects may have resulted in superior diagnostic and surgical
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performance in group II. As the magnitudes of these effects are unknown, compar-
ison of the results of part I and part II of the study, should therefore be done cau-
tiously. However, the goal of our study was not to compare the two patient groups
but to determine the overall role of US as the primary imaging modality for identifi-
cation and localization of parathyroid adenomas in patients with pHPT to undergo
MIS.
In conclusion, MIS is an imaging-guided surgical technique for treatment of
parathyroid adenomas that has considerable advantages compared to CNE. We
have demonstrated that, using the criteria outlined above, US permitted successful
selection of patients with pHPT for MIS in more than two thirds of the cases. The
adjunctive diagnostic use of spiral CT scanning allowed the selection of only a few
more patients for MIS and therefore, the added diagnostic value of CT may not
have been worth the effort, cost and risk of a radiation hazard. However, in select-
ed cases CT may play an important role in providing an operator-independent
roadmap for the surgeon. Close cooperation between surgeon and radiologist is
essential, because the MIS procedure can only be performed successfully when the
surgeon is informed in detail about location and size of the adenoma that needs to
be removed.
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Peroperative PTH testing:
confirmation of successful surgical treatment of primary
hyperparathyroidism
Smit PC, Thijssen JHH, Borel Rinkes IHM, van Vroonhoven TJMV. Peroperative PTH testing: confirmation of
successful surgical treatment of primary hyperparathyroidism. Nederlands Tijdschrift voor Geneeskunde
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Summary
Objective To study the reliability and applicability of a rapid parathormone (PTH)
test as predictor of successful surgical treatment of primary hyperparathyroidism.
Design  Prospective.
Method  All 35 consecutive patients undergoing surgery for primary hyperparathy-
roidism in the University Medical Center Utrecht, The Netherlands, between
August 1997 and August 1998, were tested just prior to surgery, and immediately
following adenomectomy. The rapid PTH test consisted of a modification of the
computerized immunometric detection by chemoluminescence.
The decrease of serum PTH as estimated with the rapid test was correlated with
surgical findings as well as postoperative serum calcium levels. In the first 25
patients (group A) the reliability of the test was investigated. In the next 10
patients (group B) the PTH test results were allowed to have implications for surgi-
cal management, i.e. an insufficient (<50%) decrease of serum PTH following
adenomectomy resulted in immediate re-exploration. 
Results The 35 patients, 22 women and 13 men, had a median age of 58 years
(range: 22-80). The results obtained with our rapid PTH test correlated fully with
both conventional PTH measurement techniques and postoperative serum calcium
levels. In group A 21/25 patients showed adequate (>50%) decrease of their
serum PTH levels; the 4 patients without such decrease were the ones displaying
persistent postoperative hypercalcemia. In group B 9/10 patients had adequate
PTH decrease immediately following adenomectomy, while in one patient this was
only attained after further exploration and excision of a second adenoma. No false-
positive or false-negative measurements were encountered.
Conclusion The rapid PTH-test used is a reliable predictor of successful adenomec-
tomy for primary hyperparathyroidism, also in minimally invasive surgery.
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Introduction
The purpose of the surgical treatment of primary hyperparathyroidism is to normal-
ize the calcium concentration in the serum. It is therefore necessary during the
operation to locate and remove the hyperfunctioning parathyroid tissue. In the
majority of the cases there is one adenoma; but two, three, or even four adenomas
occur in about 15% of the patients. Because the serum calcium concentration
from a successful operation decreases very slowly, one normally must wait until
the next postoperative day in order to be certain the intended normalization indeed
has occurred. In those cases where the serum calcium concentration has not
decreased, or decreased enough, a second operation must be performed under less
favorable conditions for both the patient as well as the surgeon.
The parathyroid hormone (PTH) has a half-life of less that five minutes 1, and
should in theory be able to be used to determine during the operation if all of the
hyperfunctioning tissue is removed. Until recently, reliable measurement of the
PTH concentration in the laboratory was too labor-intensive and too time-consum-
ing for this purpose. Now faster methods for the measurement of the PTH concen-
tration have become available, and the ideal of having proof during the operation
will be successful, is clearly in sight.
The usefulness of a recently developed, rapid PTH measurement was tested and
correlated for operative and postoperative findings in 35 patients who were operat-
ed for primary hyperparathyroidism. At the same time the effects of this new
approach for the following surgical strategy was studied.
Methods
All consecutive patients between August 1997 and September 1998 (13 months)
who were candidates for surgical treatment of their primary hyperparathyroidism
were eligible for the study. The diagnosis ‘primary hyperparathyroidism’ was
formed based on a repeated increased concentration of calcium and parathormone
in the serum. At the same time, according to protocol, a localizing diagnostic was
performed using Doppler ultrasonography and spiral computed tomography exami-
nation of the neck. The results of this determined if a conventional, systematic
neck exploration was performed, than if a direct removal of the adenoma in a min-
imally invasive way was sufficient. This direct exploration has as its disadvantage
that not all the parathyroid tissue is identified nor can it be macroscopically
CHAPTER 7 I PERIOPERATIVE PTH TESTING
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reviewed. For this limited procedure, just as with the conventional neck explo-
ration, not identified diseased glands at imaging and exploration result in a persist-
ent hypercalcemia.
At the beginning of the operation and eight minutes after the hyperfunctioning
parathyroid tissue was removed, peripheral venous blood was drawn and a PTH
measurement was done. In order to establish the reliability of the new measure-
ment in the perioperative period, no surgical conclusions were drawn from the
results of the PTH-values after resection in the first 25 patients (group A). In the
following ten patients (group B) a decrease of PTH concentration of at least 50%
was considered as evidence that all the hyperfunctioning tissue was removed. No
decrease or a decrease of less than 50% was reason to immediately perform fur-
ther neck exploration afterwards. If more adenomatous parathyroid tissue was
found, a quick PTH-measurement was again done after its removal.
Measurement of parathormone
For the measuring of PTH a new modification of the automated immunometric
(sandwich) measurement with chemoluminescence (Immulite, Diagnostic Products
Corporation (DPC Holland), Apeldoorn) was utilized 2. This measurement made
use of two purified (cultured in goats) antibodies against, respectively, the first so-
called N-terminal part (amino acids 1-34) and the last so-called C-terminal (amino
acids 44-84) part of the PTH molecule. The C-terminal antibody is bound to a
polystyrene bead and the N-terminal is recognized with the enzyme alkaline phos-
phatase, with which the chemiluminescence becomes activated after reaction with
PTH. The measurement is directed towards the measuring of intact PTH; pieces of
PTH show no cross-reaction in the assay.
The modification holds that a shorter incubation time is used than until now has
been described: the original measurement has a reaction time of 60 minutes,
while the modification is incubated for 30 minutes. The measurement is tolerant
for serum as well as ethylene diamintetra-acetate (EDTA). In practice EDTA-plas-
ma is worked with since the plasma and cells being separated from each other
directly after the blood is drawn. After being received by the laboratory and cen-
trifuged for four minutes, the assay is begun, which proceeds further automatically
in the Immulite, which is made ready for the PTH-measurement in advance. After
approximately 45 minutes the results are available after calculation with the
attached microcomputer. The sensitivity of the shortened assay (~ 0.1 pmol/L), is
practically identical to the original; the variation between measurements amounts
to 5.3% at 4.8 pmol/L, 3.0% at 34.4 pmol/L, and 3.3% at 90 pmol/L (each time
n = 10). The correlation between the long and the short method were determined
in more than 100 samples; the correlation coefficient amounted to 0.992 at a gra-
dient of 0.986, which says that the results were absolutely comparable.
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Results
The study was performed with 35 patients with primary hyperparathyroidism. It
involved 22 women and 13 men with a median age of 58 years (range: 22-80).
The median serum concentrations of calcium and parathormone were, respectively,
2.75 mmol/L (ranges: 2.51-3.81; normal: 2.20-2.60), and 13.3 pmol/L (ranges:
2.3-148.0; normal for normocalcemia: <8 pmol/L). In 26 patients (group A, 19;
group B, 7) a minimally invasive operation was performed. The other 9 patients
(group A, 6; group B, 3) underwent a conventional neck exploration.
Group A (reliability of the assay)
Of the 25 patients from this group, 21 became normocalcemic after the operation
(Table 1). The perioperatively measured decrease of the PTH serum concentration
with these patients was, with a median decrease of 82%, unmistakable.
With the four patients who still showed hypercalcemia after the operation, the
perioperatively measured PTH values showed no (two patients) or an insufficient
decrease (15% and 30%). Of these four patients, two underwent in the meantime
repeat surgery; at that a second parathyroid adenomas was found, after which this
was removed and microscopically confirmed. Upon this the perioperative PTH con-
centration decreased significantly then and normocalcemia existed after the opera-
tion. The two other patients with persistent hypercalcemia are still waiting to be
reoperated.
Group B (applicability of the assay)
This group consisted of 10 patients (Table 2). In 9 a significant decrease of the
serum PTH concentration (median decrease: 87%) was determined during the
operation. In one patient the PTH concentration barely decreased after resection of
one adenoma (from 9.4 to 7.3 pmol/L). Further exploration followed immediately,
by which a second adenoma was found and removed, followed with a significant
decrease of the PTH concentration (from 7.3 to 1.2 pmol/L). All ten patients were
normocalcemic after exploration.
In total was thus 33 times (30 times during primary exploration, 3 times during fur-
ther exploration) perioperatively a significant decrease of the serum PTH concentra-
tion established and in all these 33 cases normocalcemia later existed, as proof of a
successful exploration. In four cases (during the ‘reliability study’) the operation was
ended, while no or only a limited decrease of the serum PTH concentrations was
ascertained, which was followed by persistent hypercalcemia. There were in this
patient group, therefore, no false-negative and no false-positive results found.
CHAPTER 7 I PERIOPERATIVE PTH TESTING
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Table 1 Serum parathormone concentrations measured before and after resection of hyperfunctioning
parathyroid tissue in 25 patients with primary hyperparathyroidism (Group A, reliability study).
perioperative postoperative
serum PTH  serum calcium  normocalcemia
concentration in pmol/L  concentration in mmol/L
patient preresection postresection decrease (%) preresection postresection
1 14.0 1.4 90 2.75 2.27 yes
2 14.0 3.1 78 2.92 2.50 yes
3 8.5 0.9 89 2.66 2.18 yes
4 53.0 4.8 91 3.02 2.28 yes
5 11.4 0.1 99 2.68 1.97 yes
6 61.0 4.4 93 3.16 2.24 yes
7 12.3 2.3 81 2.75 2.11 yes
8 17.0 2.9 83 2.70 2.30 yes
9 12.0 1.0 92 2.59 1.94 yes
10 13.3 13.5 0 2.78 2.73 no *
11 27.3 2.4 91 3.01 2.18 yes
12 11.7 1.2 90 2.51 2.10 yes
13 21.0 14.2 33 2.81 2.71 no#
14 6.2 1.4 78 2.60 2.07 yes
15 25.8 1.9 93 2.87 2.35 yes
16 28.2 2.2 92 2.64 2.25 yes
17 13.9 11.9 14 2.79 2.71 no *
18 2.3 0.1 94 2.70 2.16 yes
19 11.3 0.9 92 2.63 2.25 yes
20 34.5 9.6 72 3.02 1.95 yes
10 b * 12.3 2.0 84 2.76 2.11 yes
21 4.1 2.0 52 2.70 2.20 yes
17 b * 11.5 1.3 89 2.72 2.39 yes
22 6.4 0.9 86 2.65 2.01 yes
23 15.0 4.2 72 2.94 2.40 yes
24 109.0 20.0 82 2.72 2.05 yes
25 4.6 4.5 0 2.90 2.65 no#
* reexploration is executed.
# reexploration will be executed.
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Table 2 Serum parathormone concentrations measured before and after resection of hyperfunctioning
parathyroid tissue in 10 patients with primary hyperparathyroidism (Group B, reliability study).
perioperative postoperative
serum PTH  serum calcium  normocalcemia
concentration in pmol/L  concentration in mmol/L
patient preresection postresection decrease (%) preresection postresection
1 8.3 1.5 82 2.75 1.94 yes
2 16.4 1.6 90 2.66 2.28 yes
3 8.7 1.4 84 2.60 2.14 yes
4 9.4 7.3 (1.2) 32 (84) 2.75 (2.13) yes
5 148.0 11.3 92 2.90 1.95 yes
6 12.0 2.5 79 3.01 2.15 yes
7 10.0 3.9 61 2.80 2.10 yes
8 11.1 1.0 91 2.79 2.05 yes
9 35.1 4.7 87 2.90 2.10 yes
10 61.5 11.4 82 3.80 2.55 yes
Numbers between parentheses are values after reoperation and resection of a second adenoma.
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Discussion
The results of our investigation showed that perioperative PTH-measurements can
be of good use in determining the completeness of resection of hyperfunctioning
parathyroid tissue and with that to predict the chance of success of the operative
treatment of primary hyperparathyroidism.
This finding agrees with the recently published experiences of a group Swedish
investigators 3. Going by the definition that the PTH concentration should be
decreased by at least 50% five minutes after resection and at least 60% 15 min-
utes after resection in order to be able to predict a positive result, they found a
sensitivity of 86% by the 5 minute and 97% by the 15-minute definition. The
specificity was 100%. The development of a rapid, but especially reliable PTH-
assay brings a number of not to be undermined advantages with it. In the first
place the patient can be placed in a prospect of greater certainty. Furthermore, a
decrease in the number of non-successful explorations can be expected along with
the accompanying complications of parathyroid surgery, which are seen mainly in
repeat operations. The decrease of the necessity for repeat operations, and with it
the decrease of supplementary examination and the number of hospital admit-
tances will above all be cost-efficient. Finally, the development and applicability of
the rapid PTH-assay can be seen as a definite step towards wide application of the
direct, minimally invasive treatment of primary hyperparathyroidism.
Until now most experts saw as the golden standard the bilateral, systematic explo-
ration of the neck in which all the four parathyroid glands are identified and
inspected 4. Not unjustly, incidentally, because with such a conventional neck
exploration is the change of success in experienced hands high, 95 to 97%; that
can not be said until now of less extensive explorations, of which the unilateral is
the most applied. Now that a rapid PTH-assay is available to assure the success of
the surgery, there is no hindrance standing in the way of ample application in the
less invasive approach. One of those is the technique with which we, owing to the
developments in radiology, such as echodoppler and spiral computed tomography
examination, recently achieved very promising results 5. It is then also to be
expected that the indication for operative treatment of primary hyperparathy-
roidism will be more ample than suggested before 6.
Next to the rapid PTH-assay used by us are special ‘kits’ obtainable for some time
which are so quick that the total time needed between collection of blood on the
one side and the result of the PTH measurement on the other side amounts to only
a quarter of an hour 7. The high costs associated with this method however seem
to matter when weighed against the time that is saved. It is true that we must wait
45 minutes for the results after collection of the blood samples using our method,
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but the (expensive) procedure at the operation rooms do not have to be impeded
by that. The practical solution that we found for that, and that is in the meantime
being routinely applied with success, is the following;
The patient with primary hyperparathyroidism is one of the first to be operated in
the daily schedule. When the surgeon feels that all the hyperfunctioning parathy-
roid tissue is removed, a blood sample is taken to check the PTH measurement
and the operation is ended. After that the patient, such as usually is done, goes to
the recovery room. There he/she stays in any case until the result of the PTH
measurement is known. In the majority of cases (in this group 30 of the 35
patients) the PTH concentration provides immediately the assurance of a success-
ful operation and the patient, as soon as it is anesthesiologically responsible, can
be returned to the nursing ward. The patient, by whom an insufficient decrease
was determined, went then from the recovery room back to the operation room,
where the neck exploration was continued. The extra burden for the patient stays
thus limited and our experiences teaches in the meantime that patients choose by
far this design over the uncertainty that is characteristic to the conventional course
of things.
In summary, it seems from this study with a rapid perioperative PTH assay that
this method can reliable predict the result of the operation and that it must be pos-
sible, by a consistent application to reduce the number of unsuccessful explo-
rations for primary hyperparathyroidism to practically none, even when less
invasive approaches become applied.
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Abstract
Objective To test four different non-portable PTH assays (Immulite Regular assay,
Immulite Turbo assay, Advantage Regular assay and Advantage Turbo assay) as
alternative for (expensive) portable PTH assays in predicting surgical outcome in
primary hyperparathyroidism.
Methods All consecutive patients with biochemically proven primary hyperparathy-
roidism were enrolled in this study. A decline of >50% in PTH concentration (in a
sample taken 8 minutes after resection) was defined to be predictive of postopera-
tive normocalcemia, a drop of less than 50% to indicate persistent disease. The
Immulite Regular assay was considered the reference test for perioperative meas-
urement. We prospectively tested 192 samples from 90 patients by the Immulite
Regular and Immulite Turbo assay. In addition, 101 samples from 53 patients
were tested with the Advantage Regular and Advantage Turbo assay.
Results In 80 patients postoperatively normocalcemia was correctly predicted after
a median drop in PTH concentration of 84.9% (all over 50%, measured with
Immulite Regular). When comparing preoperative and postoperative PTH levels,
the median decline using the Immulite Turbo assay was 84.0%, in the Advantage
Regular assay was calculated to be 78.2% versus 76.1% in Advantage Turbo
assay. Comparative analysis of Immulite Regular and Immulite Turbo assays
showed that they correlated extremely well (r=0.987), as for Advantage Regular
and Advantage Turbo (r=0.993). Results of Immulite Regular and Immulite Turbo
assays versus Advantage Regular and Advantage Turbo assays were discordant in
three patients (all of whom were normocalcemic on the first postoperative day). 
Conclusion Both the Immulite Regular and Immulite Turbo assays were found to be
highly accurate and moderately superior to the Advantage Regular and Advantage
Turbo assays when drawn at 8 minutes with a 50% guideline. All four alternatives
were much less expensive than the portable kits.
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Introduction
The goal of surgical treatment in primary hyperparathyroidism (pHPT) is normal-
ization of serum calcium. Since this takes at least 24 hours both surgeon and
patient are uncertain about the effect of the exploration until the first postoperative
day. With the development of less invasive techniques as alternatives for conven-
tional neck exploration (CNE) in the treatment of pHPT, the need for perioperative
assurance about the effect of the exploration has increased. The short half-life (<
3 minutes) of intact parathormone (1-84) (PTH), combined with suppression of
PTH secretion for hours after parathyroid adenomectomy, contribute to fast clear-
ance from the circulation. Early studies on intraoperative PTH testing to ascertain
the success of unilateral explorations, by Nussbaum 1 and Irvin 2 reported the
results of modified immunoradiometric assays (IRMA). Although this test provided
results within 25 minutes, it has not been widely accepted. The short half-life of
isotopes (and the ‘shelf-life’ of these intraoperative PTH assays), the necessary
safety precautions (including proper disposal of waste products), a false negative
rate of 15%, and the associated high costs, initially limited use of the assay to a
few specialized centers 2. Other rapid tests were developed but despite the techno-
logical advances of these tests the potential of intraoperative measurement was
not realized until the introduction of modified immunochemoluminometric assay
kits that can be used in the operating theatre 3  4. Nowadays, these commercially
available portable kits can perform PTH measurements within 15 minutes with
sensitivity rates up to 96%,  specificity of ~100% and an overall accuracy of 97%
3 5. It cannot be denied that these tests are highly effective in providing true intra-
operative results, but the need for instrument performance checks, for generating
calibration curves and for assay quality control before surgery and the high cost
preclude their widespread use. In the search for an alternative rapid PTH assay to
these portable kits, we have evaluated the accuracy of four non-portable ‘quick’
tests as predictors of surgical success in primary hyperparathyroidism. The follow-
ing assays were investigated: 1) the Immulite Regular PTH assay (60-minute incu-
bation), 2) the Immulite Turbo PTH assay (10-minute incubation), 3) the
Advantage Regular PTH assay (25-minute incubation), and 4) the Advantage
Turbo PTH assay (12-minute incubation).
CHAPTER 8 I PERIOPERATIVE PTH TESTING
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Methods
Parathormone assays
Parathormone levels in blood were assessed by four different commercially avail-
able, non-portable PTH assays. Two manufactured by Diagnostic Products
Corporation (DPC, Los Angeles, Ca, USA) and two manufactured by Nichols
Institute Diagnostics (San Juan Capistrano, Ca, USA). Both of these companies
market a Standard assay (DPC: Immulite Regular assay and Nichols: Advantage
Regular), and a more rapid, so-called Turbo assay (DPC: Immulite Turbo assay and
Nichols: Advantage Turbo assay).
I) The Immulite Regular and the Immulite Turbo assays are analyzed using the
DPC Analyzer. Both assays use a pair of antibodies, respectively directed at the
C-terminal part of PTH (immobilized to solid phase) and the N-terminal region.
The main difference between these assays is the much shorter time of incuba-
tion when the Turbo-mode is utilized, requiring a separate set of reagents. The
Immulite Turbo assay can only be utilized in the Turbo-mode of the Immulite
software. This results in a less sensitive assay, the Immulite Regular assay hav-
ing a lower limit of detection for PTH of 0.4 pmol/L whereas the sensitivity of
the Turbo equals 1 pmol/L. Interassay variations for both tests during the year
2000 were between 7 and 10%.
After proper calibration of the Analyzer, total time between start of processing
an EDTA-plasma sample and the first result is 75 minutes for the Immulite
Regular assay and 15 minutes for the Immulite Turbo assay. In the Regular
mode 50 µl and in the Turbo mode 100 µl of EDTA-plasma is used.
II) The Advantage Regular Intact PTH and the Advantage Turbo Intact PTH
assays, of Nichols Institute Diagnostics. In both variants of these assays identi-
cal reagents are used, the only difference in processing is the incubation time
and the requirement for special software to operate the Analyzer in the Turbo-
mode. The sensitivity of the Advantage Regular assay is 0.5 pmol/L whereas
no official data are available for the Advantage Turbo assay but its sensitivity is
about 1 pmol/L. Interassay variation measured over the past year of the
Advantage Regular assay was approximately 11%, whereas no such data are
available for the Advantage Turbo assay.
After proper calibration of the Analyzer, total time between start of processing
an EDTA-plasma sample and the first result is approximately 40 minutes in the
Advantage mode and 17 minutes in the Turbo mode. Both the Advantage
Regular assay and the Advantage Turbo assay use 150 µl of EDTA-plasma.
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Patients
All consecutive patients with biochemically proven primary hyperparathyroidism
were enrolled in this prospective study after informed consent was obtained.
Previous (para)thyroid surgery was considered a criterion for exclusion. In an earli-
er study we had tested the reliability and applicability (reliability study) of the
Immulite Regular assay in 25 patients. A decline of more than 50% in PTH con-
centration (in a sample taken 8 minutes after resection) was defined to be predic-
tive of postoperative normocalcemia, a drop of less than 50% to indicate persistent
disease. Once the Immulite Regular test results were proven to correlate fully with
postoperative serum calcium levels, we introduced it to our surgical management
protocol 6.
Study design
In the present study the Immulite Regular assay was considered the reference test
for perioperative PTH measurement. We prospectively tested 192 samples from
90 patients by the Immulite Regular assay. Once the Immulite Turbo assay
became available we tested the same 192 samples with that as well, and com-
pared the results of both methods. In addition, 101 samples from 53 patients
were tested with the Advantage Regular assay and the Advantage Turbo assay.
Results of these two tests were correlated to postoperative calcium levels as well
as to the Immulite Regular assay. In addition, we compared the results of the
Advantage Turbo and the Advantage Regular assays.
Protocol
One day prior to surgery the Endocrine laboratories were informed about the
scheduled exploration so that such necessary preparations as calibration of the
Analyzer could take place. Baseline peripheral plasma samples (3 ml EDTA (k3)
Vacutainer®) were taken at the operation room after anesthesia was induced but
before exploration. Eight minutes after resection of a suspected adenoma the next
sample was taken, transported to the Endocrinology laboratories and subsequently
analyzed. After exploration, patients were extubated in the operation room and
transported to the recovery unit. Patients were only sent back to the surgical ward
if the test results were indicative of successful exploration. If not, they were taken
back to theatre, as soon as it was ready, for re-exploration.
Operative success was defined as normalized serum calcium levels on the first
postoperative day and 1 week and 1 month later.
Depending on the preoperative imaging results patients underwent either minimal-
ly invasive adenomectomy (MIA) or conventional neck exploration (CNE). If a soli-
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tary adenoma was visualized, a local procedure through a 2-3 cm incision at the
ventral border of the sternocleidomastoid muscle was performed as described else-
where 7. After identification and resection of the adenoma the procedure was ter-
minated. If no adenoma was found, however, the exploration was converted into
CNE, comprising a systematic, bilateral exploration through a 10-12 cm collar
incision, with identification of the four parathyroids and resection of the causative
adenoma(s) based on gross morphologic features. If MIA (or CNE) failed the re-
exploration consisted of a CNE.
Results
Ninety patients with a biochemically proven pHPT were selected for surgery. Their
median age was 59 years (range 22-81), with women outnumbering men 62 to
28. The median preoperative calcium level was 2.89 mmol/L (2.55-4.10; normal
2.20-2.60) while the PTH level was 14.1 pmol/L (range: 10-220; normal <8
pmol/L). Based upon preoperative imaging results 64 patients were selected for
MIA, 26 for CNE. Two samples (one baseline sample and one postresection sam-
ple, total 156 samples) were drawn from 78 patients,  three (total 36 samples)
from the other 12, in whom multiple gland disease was suspected or to ascertain
success after delayed fall in PTH.
In 80 patients postoperative normocalcemia was correctly predicted after a median
drop in PTH concentration of 84.9% (all >50 %, measured with Immulite Regular
assay). After a thorough exploration (CNE) one patient displayed a drop in PTH
concentration of 47.4% at 8 minutes after resection. However, as an exception to
the protocol, this patient did not undergo immediate re-exploration because during
exploration all parathyroid tissue had been identified (one adenoma and three nor-
mal parathyroid glands). The chance of a fifth parathyroid gland was considered,
but rejected because of the very low incidence of supernumerary glands. The next
day the patient’s serum calcium level was normal (2.25 mmol/L).
In two patients falls of 40% and 48%, respectively, suggested surgical failure.
Because this decline was so close to the 50% cut-off point we decided to draw a
third sample at 30 minutes after resection. These samples showed respective
declines of 94% and 99.5% and next day their calcium levels were normal, and
this was confirmed during follow-up. Seven patients showed a fall in PTH of less
than 50% (falls of 25%, 12%, 2%, increases to 123%, 124%, 140% and
152%). All were re-explored (as is discussed below) and a (second) causative ade-
noma was found and resected, after which their serum calcium concentrations fell
to normal.
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Sixty-four patients underwent MIA. Fifty-nine (92%) showed an adequate decline
in PTH level and were normocalcemic in the postoperative period. Minimally inva-
sive adenomectomy was followed by an inadequate fall in PTH, requiring immedi-
ate re-exploration in two patients at which a ‘missed’ causative adenoma was
found and resected. Both became normocalcemic postoperatively. The other three
displayed persistent abnormality and were re-explored at a later stage (these fail-
ures were monitored during the ‘reliability study’). At re-exploration a (second)
adenoma was resected in all of them (multiple gland disease in two, missed ade-
noma in one) and their serum calcium reverted to normal.
After CNE, 24/26 patients (92%) showed a fall in PTH concentration of more than
50 %, and all were proven to be normocalcemic. The other two patients had per-
sistent disease after a fall of less than 50%, necessitating re-exploration. In the
first patient a second adenoma was found in the thymus, while an additional ade-
noma was localized and subsequently resected from the mediastinum in the sec-
ond. Both became normocalcemic after re-exploration.
Comparative analyses of PTH assays
Comparative analysis of the results of Immulite Regular and Immulite Turbo assays
(192 samples) yielded the following equation:
Immulite Turbo = 0.807 x Immulite Regular + 1.2; r = 0.987 (p < 0.0001)
(Figure 1).
This means that both methods correlated extremely well (r = 0.987), though the
test results with the Immulite Turbo assay are somewhat lower (Immulite Turbo =
0.807 x Immulite Regular) than those with the Immulite Regular assay.
Comparing baseline values and postresection values measured by the Advantage
Regular and Immulite Regular assays, gave the following equation: 
For baseline Advantage Regular = 0.701 x Immulite Regular + 1.0; r = 0.966
and for postresection Advantage Regular = 0.917x Immulite Regular + 0.5; r =
0.930 (Figure 2). This implies that the baseline values are 1.4 times higher when
measured with Immulite Regular assay, while postresection values are almost
equal. As a result the decline in PTH levels is relatively smaller in the Advantage
Regular assay.
The results of 101 samples from 53 patients tested with Advantage Regular assay
and Advantage Turbo assay showed: 
Advantage Turbo = 1.07x Advantage Regular - 0.5; r = 0.993 (Figure 3),
meaning that these two techniques also correlate extremely well.
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Figure 1 Comparative analysis of Immulite Regular assay and Immulite Turbo
assay.
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Figure 2 Comparative analysis of Immulite Regular assay and Advantage Regular
assay.
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In calculating costs (for all four techniques) the following factors were considered:
materials (reagents) used, personal salaries and wages, and overhead costs. We
calculated the costs per patient (two assays) to be approximately 100 US dollars.
Discrepancies in parathormone assays
When comparing preoperative and postoperative PTH levels, the median decline
using the Immulite Regular assay was 84.9% (range -99.6 to +153.8). Similarly
the median decline as judged by the Immulite Turbo assay was 84.0% (- 97 to
+153). The only discrepancy between these two methods was a patient in whom
the Immulite Regular assay showed a drop of 57.3%, while the Immulite Turbo
assay showed a drop of only 48.5%. The postoperative serum calcium, however,
returned to normal on day one.
The median decline in the Advantage Regular assay was calculated to be 78.2% (-
92.7 to +125.7) versus 76.1% in Advantage Turbo  (-90.6 to +121.6).
The results of the Immulite Regular and Immulite Turbo assays versus the
Advantage Regular and Advantage Turbo assays were discordant in three patients
(all of whom were normocalcemic on the first postoperative day). In the first
patient, the Immulite Regular and Immulite Turbo assays showed declines of 90%
and 79%, respectively, while the Advantage Regular and Advantage Turbo assays
recorded declines of 44% and 41%. In the second patient declines of 72% and
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Figure 3 Comparative analysis of Advantage Regular assay and Advantage Turbo
assay.
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65% were observed in the Immulite Regular and Immulite Turbo assays. In con-
trast, rises to 126% and 122% of baseline values were observed using the
Advantage Regular and Advantage Turbo assays. The adenoma in this patient,
however, was very large and was accidentally fragmented during resection.
In the third patient a delayed fall in PTH was seen: a decrease of 52% was
observed with the Immulite Regular and Immulite Turbo assays, but a fall of 9%
and a rise of 20% were found by the Advantage Regular and Advantage Turbo
assays respectively. However, PTH concentration measured in the 30 minute sam-
ple showed concentrations of 5.6% and 9.5% compared with baseline values
using Advantage Regular and Advantage Turbo assays. 
Discussion
Rapid PTH assay has become essential with the introduction of limited forms of
parathyroid surgery. The use of portable non-radioactive kits that can be carried on
a trolley has allowed assays to be performed in the operating theatre providing true
intraoperative information. As a result, operating time and hospital stay can be
reduced, leading to cost savings. Chen et al 8 reported a 50% reduction in hospital
charges with outpatient minimally invasive parathyroidectomy. Although the relia-
bility of the portable tests they used was reported to be excellent, the costs
(approximately 1,000 US dollar a test) were about one third of mean total hospital
charges per patient (3,174 US dollars). In our experience the mean total costs for
MIA were calculated to be approximately 1,200 US dollars 9, which included the
costs for the Immulite Regular assay (approximately 100 US dollars a test).
Although the advantages of a portable kit, i.e. true intraoperative information on
surgical outcome, precluding the need for second procedures, are evident, the high
costs of such kits outweighs their advantages. The Immulite Regular test gave
results within 75 minutes. It correlated in 97% of patients (all but one) with the
postoperative serum calcium, and was concluded to be very reliable.
Despite the success of the perioperative PTH assays the following limitation should
be noted. In three patients postexcision values fell to near 50% of the preoperative
figure. The surgeon judged these patients to be cured and they were not immedi-
ately re-explored. This was confirmed in two patients after that a second postexci-
sion sample showed an adequate decline. The cause of delayed fall in PTH
concentration was not clear, but a low initial baseline PTH concentration and the
manipulation of the adenoma during mobilization are possible reasons 10.
Manipulation of an adenoma may result in release of PTH or of proteins that
resemble PTH that can potentially interfere with the assay. In addition, the use of a
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50% decline after 8 minutes as a cut-off level does not take in account inter-indi-
vidual variability in PTH half-life 10 11.
The Immulite Turbo assay was concluded to be a reliable test, which correlated
extremely well with the Immulite Regular assay. Only in one patient was a fall of
57.3% shown by the Immulite Regular assay and close to 50% by the Immulite
Turbo assay. No other problems were encountered, and it produced results within
15 minutes. Taking into account this and other examples of ‘delayed’ decline in
PTH levels following correct surgery, we believe it is advisable that, in cases of
PTH falls close to 50%, to preclude the possibility of a delayed fall, a third sample
should be taken before deciding on re-exploration.
From a logistic point of view the procedure might be as follows: 8 minutes after
resection the sample will be drawn; delivery to the Endocrine laboratory takes a lit-
tle under 10 minutes. Since the Analyzer has been calibrated in advance, process-
ing can take place immediately, providing results within 15 minutes. In total, test
results become available after approximately 30 minutes. The surgeon can thus
await the results with the patient under anesthesia, so avoiding the need for later
re-intubation and re-exploration when the initial operation was not successful.
The Advantage Regular and Advantage Turbo assays were concluded to be less
accurate than the Immulite Regular and Immulite Turbo assays, though the rea-
sons for this remain unclear. However, we may speculate that differences in stan-
dardization of instruments and/or the detection of additional fragments of PTH by
the latter two tests might explain the difference. The discrepancies between the
methods do not necessarily prevent the use of the Advantage Regular and
Advantage Turbo assays as perioperative or intraoperative PTH assays. Using a
guideline of 50% decline at 8 minutes produces suboptimal results in both assays,
and the test should therefore be prolonged when using Advantage Regular and
Advantage Turbo assays.
In conclusion, the use of a perioperative PTH assay is essential in the treatment of
primary hyperparathyroidism. Both the Immulite Regular and Immulite Turbo
assays were found to be highly accurate and moderately superior to the Advantage
Regular and Advantage Turbo assays when drawn at 8 minutes with a 50% guide-
line. All four alternatives were much less expensive than the portable kits.
CHAPTER 8 I PERIOPERATIVE PTH TESTING
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Abstract
Objective To obtain knowledge on cost-relations between minimally invasive ade-
nomectomy and conventional neck exploration in patients with primary hyper-
parathyroidism.
Summary background data Imaging modalities and measurement of perioperative
parathormone concentration facilitate successful minimally invasive adenomecto-
my. As a result reduction in operative time and admission days may be anticipated
together with potential reduction in costs.
Methods  Prospectively, 164 consecutive patients with biochemically proven pri-
mary hyperparathyroidism were enrolled. Because of variation in imaging protocol
over time, 126 patients underwent ultrasonography and computed tomography; in
38 patients ultrasonography was the sole modality. Data were collected from the
first preoperative surgical consultation to discharge from follow-up. Costs were cal-
culated by multiplying patients’ resources by unit costs. To obtain insight in the
effect of changing appreciable variables multiple sensitivity analyses were per-
formed.
Overall 123 patients were selected for minimally invasive adenomectomy, 41 for
conventional neck exploration. Mean costs for minimally invasive adenomectomy
were calculated to be € 1288 +/- 431 (mean, +/- SD) and for conventional neck
exploration € 2106 +/- 1070. Sensitivity analyses showed that an increase in
total average costs of 63%, an increase in operative time to 272 minutes, prolon-
gation of admission with 2.5 days, or a failure rate of 54% in the minimally inva-
sive adenomectomy group would result in a break-even point with equal costs of
both alternatives.
Conclusion Minimally invasive adenomectomy, including preoperative imaging is
less expensive than conventional neck exploration in the treatment of primary
hyperparathyroidism.
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Introduction
For many years conventional neck exploration (CNE) has been the gold standard in
the surgical treatment of primary hyperparathyroidism (pHPT), but with the advent
of minimally invasive surgery, this pre-eminence has been questioned. As primary
hyperparathyroidism is caused by a solitary adenoma in the vast majority of cases,
CNE involves unnecessarily extensive exploration of normal parathyroid glands and
prolonged operating time. Several authors have recommended unilateral neck
exploration for that reason 1 2, and moreover, direct adenomectomy can now be
performed with promising results 3 4 5.
Recently, we have introduced a technique of direct, minimally invasive adenomec-
tomy (MIA) based on preoperative localization studies by ultrasonography (US) and
spiral computed tomography scanning (CT) 6.
The results of this approach in our first 110 patients led us to conclude that MIA is
a safe and effective alternative to CNE and may replace CNE in approximately two
thirds of patients with pHPT 7.
Given current limited resources, it is of vital importance to obtain knowledge on
cost-relations between these two alternatives. The current study contains a
prospective cost-analysis of 164 consecutive patients undergoing CNE or MIA for
primary hyperparathyroidism. In addition, we have performed sensitivity analyses
to obtain an impression of the effect of changes in particular variables, for example
operative time and admission time.
Methods
Patients
Between October 1994 and July 2000, 164 patients with biochemically proven
primary hyperparathyroidism were enrolled in this study. Previous (para)thyroid
surgery, familial hyperparathyroidism and multiple endocrine neoplasia syndrome
were considered criteria for exclusion. After informed consent had been obtained
for MIA, when this was thought to be possible, the patient was scheduled for pre-
operative imaging using US and CT. If the test results unequivocally indicated soli-
tary disease the patient was advised to undergo MIA. On the other hand, if test
results were equivocal or indicated multiglandular disease the patient was advised
to undergo CNE. Surgery took place during a regular hospital admission and
patients were discharged after surgery when they were able to look after them-
selves unaided and only needed oral analgesics for pain management.
CHAPTER 9 I COST ANALYSIS
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Protocol
In this study four sub-groups are identified on basis of a) variation of preoperative
imaging protocols over time b) the introduction of a perioperative parathormone
(PTH) assay in late 1998. In the first series of 65 patients (October 1994 - March
1997) both US and CT were performed as preoperative localization studies. In the
second series (April 1997 - October 1998, 45 patients) US was used alone unless
its results were inconclusive, when CT was added. Because initial imaging with US
produced inferior results 7 we reintroduced both modalities in the routine as preop-
erative work-up since then (November 1998 - July 2000, 54 patients). As we
have described elsewhere, we started in June 1998 to use a perioperative PTH
assay to predict the success of surgery for primary hyperparathyroidism, after the
assay had been shown to agree fully with both conventional PTH assays and post-
operative serum calcium measurements in over 100 patients 8.
Data collection
For the purpose of this cost analysis resources of 164 patients were prospectively
measured. Resources before inclusion were not included as these were considered
to be equal for all patients with primary hyperparathyroidism (i.e. diagnostic pro-
cedures for the diagnosis of primary hyperparathyroidism).
Data were collected from the first (preoperative) surgical consultation at the outpa-
tient department to discharge from follow-up and counted for all 164 patients.
It was expected that all patients would receive regular intravenous anesthesia and
be monitored on a normal ward postoperatively. Nevertheless, we recorded type of
anesthesia and level of care (i.e. intensive care, medium care or normal care).
Procedures and measurement of resources
As the result of both operations is the same, we chose to perform a cost-minimisa-
tion-analysis 9. A hospital-perspective was taken, since it is unlikely to expect dif-
ferences in societal costs. The following parameters were identified as appreciable
units and counted for each patient;
Before admission:
1 preoperative consultation (including laboratory testing)
2 imaging strategy (ultrasonography, computed tomography, nuclear mapping)
Admission:
3 total time in operating theatre (minutes), operation time (minutes) defined as
the time between skin incision and - closure, time on recovery ward (minutes)
4 number of days in hospital
5 perioperative parathormone assay
6 in-hospital complications: conversion in CNE, reexploration, and miscella-
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neous costs due to failed surgery, bleeding or infection, vocal cord paralysis,
clinical hypocalcemia
7 laboratory tests
After discharge
8 number of postoperative consultations (outpatient department, emergency
room)
9 late post-operative complications (described under 6)
10 miscellaneous costs due to recurrent disease (list 1-10)
Calculation of costs
Costs were calculated by multiplying patients’ resources by unit costs 10. The costs
of materials and anesthesia, considered equal in both groups and based on average
consumption, were provided by the department of financial administration of the
University Medical Center Utrecht (The Netherlands), based upon 1999 guidelines.
Costs for nursing and medical personnel were calculated using the bottom-up prin-
ciple 11. According to this principle costs are calculated based on actual consumed
time and resources. Based on personnel salaries and wages (1999 guideline) costs
were calculated per time unit (minute) and multiplied by actual consumed time
during operation and recovery time.
Costs for hospital days and outpatient consultations were calculated according to
the guidelines of the Dutch Ministry of Health, Welfare and Sports issued in 1999
12 and include all relevant overhead costs of administration and management,
other hospital departments (cleaning, maintenance) and housing. General over-
head costs were not used, since these figures are inaccurate and not generally rep-
resentative on account of inter-hospital variability in financial systems. Costs of
PTH assays and other laboratory tests were provided by laboratory administration
of the University Medical Center Utrecht (The Netherlands). In cases of clinical
hypocalcemia patients were treated with oral calcium (CalciumSandoz®) and alfa-
calcidol (Etalpha tablets®). Average retail prices for medication in the Netherlands
were used 13.
All costs were calculated in Euro’s (€). The official exchange rate at January 15,
2001 was 1€ = 0,9439 US Dollar.
Outcome assessment
The clinically most relevant outcome of surgical intervention in pHPT is failure or
success, defined respectively as postoperative serum calcium concentrations above
or below 2.60 mmol/L.
CHAPTER 9 I COST ANALYSIS
95
09. hoofdstuk 09  23-07-2001  09:51  Pagina 95
Sensitivity analysis
Sensitivity analyses give insight into the effects of change of an important variable
on total average costs. Variables were identified to be important if their costs were
appreciable in relation to the total costs and if they were liable to significant
change (for example operative time or admission time). We chose to perform a so-
called threshold analysis of each variable. This analysis uses the basic assumption
that total average costs are equal in both alternatives. Then, the percentage in
change of the variable is calculated. This gives insight into the degree of change,
which is required to eliminate differences in costs.
The following four variables were identified:
1 Operating time. Individual variation in personal skills and experience influences
operating time.
2 Admission days. Duration of admission varies between different reported stud-
ies. We calculated (a) how long an MIA patient’s admission could be prolonged
to bring the costs up to those of CNE and (b) the effect on CNE costs of reduc-
ing admission to one day.
3 Failure rate. Failure rate varies in MIA and CNE with individual experience.
4 Imaging. Conventional exploration can be done safely and effectively without
preoperative imaging. For comparative purposes we therefore also calculated
total average costs in MIA with all imaging costs charged to MIA.
Finally, we performed a fifth sensitivity analysis based upon the assumption that
PTH assay can be performed in all future patients with primary hyperparathy-
roidism. Consequently, surgical failure will be identified within one hour after sur-
gery and this will result in immediate re-exploration without the additional costs of
secondary admission, imaging and laboratory tests. We calculated the costs of MIA
and CNE if PTH assay was performed in all cases.
Statistical analysis
Costs are presented as means with their standard deviation. For normally distrib-
uted, continuous data the Student’s t-test was used to detect statistically signifi-
cant differences between groups. Not normally distributed data were represented
as medians with their interquartile ranges (IQR). We used the Mann-Whitney U-
test to test differences between medians. A chi-square statistic was used to test
independence between two categories of data. If an expected value of one of the
categories was less than five, we used a Fisher-exact test. A p value of <0.05 was
considered statistically significant.
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Results
Patients
Resources were recorded for 123 patients in the MIA group, 41 in the CNE group.
Patients’ characteristics are listed in Table 1. All patients underwent US, and 126
patients additionally CT. Two patients underwent (on their own request) additional
sestamibi-technetium99m scintigraphy (Sestamibi scintigraphy) after inconclusive
US and CT to exclude the possibility of mediastinal adenoma. All patients were
treated in normal hospital setting. No differences were recorded in the type of
anesthesia and intensity of care.
Minimally invasive adenomectomy group (123);
Minimally invasive adenomectomy was immediately successful in 113 patients
(92%), as judged by postoperative normocalcemia, recorded on the first postoper-
ative day. Because the localized adenoma could not be found during initial explo-
ration, MIA was converted to CNE in four patients resulting in postoperative
normocalcemia. In the period before the implementation of PTH assay to our pro-
tocol, three patients displayed persistent hypercalcemia in the postoperative period
and underwent successful reexploration at a later stage. Perioperative PTH assay
identified three ‘potential failures’ after which immediate re-exploration followed,
which resulted in resection of the causative adenoma.
Initial success, defined as postoperative normocalcemia at the first postoperative
day was thus recorded in 120 patients (98%) (113 immediate successes + 4
converted MIA + 3 immediate re-explorations).
Conventional Neck Exploration group (44);
Two (5%) failures were recorded after conventional exploration. The first patient
displayed persistent hypercalcemia on the first postoperative day and was re-
explored at a later stage, during which a third, initially missed adenoma was found
in the retrosternal thymus. Perioperative PTH assay correctly predicted persistent
hypercalcemia in the second patient after three normal parathyroid glands were
identified but no adenoma could be localized in the neck. Additional Sestamibi
scintigraphy localized the missing adenoma in the mediastinum, whence it was
subsequently resected after median sternotomy.
Hence, the initial success rate (defined as postoperative normocalcemia (serum
calcium between 2.20-2.60 mmol/L) on day one) was 98% (120/123) in MIA
and 95% (42/44) in CNE (NS). Until today (median follow-up 41.5 months, IQR
22-52) no recurrent disease has been documented.
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Resources and costs
Resources could be determined for all patients and are listed in Table 2.
The median operation time was 20 minutes (IQR 15-25) for MIA and 75 minutes
(70-90) for CNE (p<0.0005). Median additional time in the operation room (time
in the operation room minus exploration time) for preoperative and postoperative
anesthetic care was 42 (36-50) minutes for MIA versus 40 (29-54) minutes for
CNE. No significant difference (p<0.808) was measured in median recovery time
between MIA (115 minutes) and CNE (117 minutes), whereas median admission
was significantly shorter (p<0.0005) in MIA (2 days) versus CNE (3days).
Owing to surgical failure, vocal cord paralysis or clinically significant hypocal-
cemia, 30 additional consultations (15 in both groups, 12% MIA and 34% CNE)
were necessary, 32 additional laboratory tests for serum calcium were performed,
and 11 patients needed supplementary calcium. Failure after MIA resulted in re-
exploration on the same day in three patients. Three other failures in the MIA
group underwent re-exploration during a second admission. Two of them had addi-
tional Sestamibi scintigraphy before being re-explored. As a consequence, a total
of 380 minutes of exploration time and 9 admission days were added to the MIA
group. Two failures in the CNE group were responsible for 165 additional operative
98
Table 1 Patient characteristics.
MIA CNE
Patients (n) 123 41
Age (years) 59 60
Male / Female 37/86 (30/70%) 12/29 (29/71%)
Asymptomatic (n) 92 (75%) 29 (71%)
Symptoms (n) 31 (25%) 12 (29%)
Nephrolithiasis 17 8
Bone pain 10 4
Abdominal complaints 3 2
Miscellaneous 12 4
Serum calcium *
Preoperative (mmol/L) 2.84 (2.35-3.60) 2.85 (2.50-3.88)
Postoperative (mmol/L) 2.25 (1.61-2.80) 2.29 (1.81-2.64)
Preoperative PTH † (pmol/L) 12.5 (4.9-180) 13.1 (9-234)
MIA minimally invasive adenomectomy.
CNE conventional neck exploration.
* Serum calcium normal 2.20-2.60 mmol/L.
† Preoperative PTH normal <8 pmol/L.
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Table 2 Measurement of resources.
MIA CNE
Pre-admission phase
Consultation 123 41
Ultrasonography 123 41
Computed tomography 90 36
MIBI 0 2
Admission phase
Operative time (average in min) 20 70
Additional time in operation room (average in min) 42 40
Recovery time (average in min) 115 117
Hospital days (average in days) 2 3
Perioperative PTH assay 57 24
Laboratory tests 123 41
Post admission phase
Consultation 138 56
Recurrent disease 0 0
Complications (miscellaneous) 0 0
Laboratory tests 136 55
Complications
Conversion 4 0
Additional imaging US 2 0
CT 0 0
MIBI 2 2
Reexploration 6 2
Operative time (average in min) 63 83
Additional time in operation room (average in min) 43 45
Recovery time (average in min) 108 140
Hospital stay (average in days) 3 8.5
Perioperative PTH assay 4 2
Laboratory tests 3 2
Temporary hypocalcemia 5 6
Miscellaneous temporary vocal cord paralysis 2 1
Bleeding/infection 0 0
Data are given in numbers, unless stated otherwise.
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minutes and 17 extra days in hospital, 12 of these days being attributable to the
patient who had sternotomy. Both these patients had US and Sestamibi scintigra-
phy in their work-up before reexploration.
Resources were multiplied by unit costs to obtain total costs. Table 3 shows the
costs for preoperative work-up, operation and admission costs, complications and
postoperative follow-up for both groups. Mean total costs (+/- SD) were calculated
to be € 1,288 +/- 431 for MIA and € 2,106 +/- 1070 for CNE (p<0.0005).
Sensitivity analyses
The analysis for MIA shows that an increase in average total costs of 63% would
result in a break-even point for total hospital costs (Table 4).
The first sensitivity analysis revealed that operation time of MIA may increase (with
1460%) to 272 minutes before the costs of MIA equal those of CNE.
Similarly a prolongation of 2.5 days (225%) of admission time in MIA would equal
total costs of both methods. If, theoretically, admission for CNE would be reduced
to one day, total average cost would decrease to € 1,377 (7% more expensive
than MIA).
From the third analysis it can be calculated that the maximum allowable failure
rate for MIA is 54%. This is based on recorded resources of failed MIA and the cal-
culation that the average costs for reexploration in MIA is € 1,491 per reexplo-
100
Table 3 Cost of main resources (Euro’s).
MIA CNE
Consultation 10,659 3,962
Imaging 19,311 8,824
Surgical supplies 13,070 4,357
Anesthetic supplies 5,582 1,861
Recovery room supplies 391 130
Personal operation cost 9,373 10,190
Personal perioperative period cost 7,010 2,264
Personal recovery cost 6,677 2,297
Hospital stays 75,878 42,960
Perioperative PTH assay 1,467 625
Laboratory tests 1,783 667
Additional cost of complications 7,203 8,177
Total costs from hospital perspective 158,404 86,314
Average cost per patient (+/- SD) 1,288 +/- 431 2,106 +/-1070
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ration, indicating that average total costs of MIA and CNE are equalized after 67
(67/123) failed MIA procedures.
Our fourth sensitivity analysis calculated costs of CNE in our series disregarding
imaging costs. After deducting total imaging costs, the total average cost for CNE
reduces to € 1,890 (reduction of 10%). If all imaging costs are then charged to
MIA, costs in MIA rise to an average of € 1,360 (increase of 6%).
Finally, if PTH measurement would be used in every exploration, costs for MIA and
CNE become € 1,242 and € 1,977 respectively; a further additional saving of 4 %
and 6 % respectively.
Discussion
Conventional neck exploration was found to be more expensive than minimally
invasive adenomectomy from a hospital point of view. Three dominant features of
the minimally invasive technique that contribute towards the disparity in costs
were identified. Firstly, since the exploration is limited to the diseased gland only,
operative time is significantly shorter, but well comparable with reported 2 3 explo-
ration times of 25-30 minutes in similar limited access parathyroid surgery.
Secondly, admission time is reduced from three to two days in favor of MIA.
However, an admission time of three days, as we found in our study after bilateral
exploration, is longer than the admission times of 1.4 to 1.9 days after compara-
ble surgery reported in recent papers 14 15. Therefore, we recalculated costs, using
admission time as a variable in the sensitivity analysis. This showed that a reduc-
tion of stay to one day made costs compatible. However, if the assumption is made
that admission time in CNE is reduced, it may also concomitantly be reduced in
MIA, and thus lead to further cost reduction in the latter group. Furthermore, it
should be realized that further cost reduction might be expected from MIA, when
executed in day-care setting using intravenous sedation combined with the use of
local anesthesia 2.
Thirdly preoperative imaging is a prerequisite to select patients for MIA, but we
believe this is defensible because imaging in patients with primary hyperparathy-
roidism will result in identification of suitable patients for MIA, which is considered
to be beneficial for patients with primary hyperparathyroidism. We agree with the
statement that imaging is of no added value in first time CNE. Imaging consumed
about 12 percent of the total budget in MIA (10 percent in CNE) but it resulted in
MIA being performed in 75% (123/164). The fourth sensitivity analysis showed
differences of 47 percent and 39 percent in costs between MIA and CNE after
imaging costs were firstly denied in CNE and then allocated to MIA.
It is vital to realize that sensitivity analyses change only one variable at a time,
102
09. hoofdstuk 09  23-07-2001  09:51  Pagina 102
whereas in reality this is not the case. For example, if operative time is prolonged
with four-and-half hours in MIA, admission time will probably increase as well.
The use of a perioperative parathormone assay as predictor of successful surgical
treatment will facilitate ‘delayed’ conversion the same day when necessary during
MIA or continuing exploration after CNE, resulting in limited additional work-up
and need for secondary admissions for re-exploration. We calculated in our last
sensitivity analysis that the use of perioperative parathormone assay results in an
additional cost saving of 4 percent in MIA and 6 percent in CNE. However, even if
we calculate total costs for failed MIA, using all records including those of failures
before we began to use perioperative parathormone assay, it can be demonstrated
that a maximum allowable failure rate of 54 percent in MIA will equalize costs
with CNE. This is unlikely to occur and therefore we believe the outcomes of our
results are robust.
We did not perform a randomized study. This does not necessarily vitiate the quali-
ty of our prospective comparison. Indeed, our groups are well comparable.
Effectiveness for instance in terms of quality of life or morbidity and mortality is
unlikely to differ between the two procedures. It is therefore completely justifiable
to perform a cost-minimisation-analysis instead of a cost-effectiveness-analysis.
However, if it had been recorded, post-operative pain might have been less in MIA
patients, enhancing patient satisfaction and allowing them to resume normal life
and return to work earlier. This would have counted in favor of MIA, and resulted
in a larger cost difference from CNE. Furthermore, a hospital perspective was pre-
ferred over a societal perspective because societal costs are unlikely to differ
between both alternatives.
In conclusion, minimally invasive adenomectomy is cheaper than conventional
neck exploration for primary hyperparathyroidism. Given the present development
of the standard use of perioperative PTH assay and the trend toward a shorter hos-
pital stay after both procedures, we expect minimally invasive adenomectomy to
be a safe, effective and cheap alternative to conventional neck exploration.
CHAPTER 9 I COST ANALYSIS
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Introduction
Since the introduction in the 1970s of the unilateral approach in surgery for pri-
mary hyperparathyroidism by Wang 1, authors have increasingly been recommend-
ing limited forms of parathyroid surgery 2 3. Although unilateral explorations reduce
operation time and admission days, decrease operative risk and give better cos-
metic results, the debate about the best surgical treatment for primary hyper-
parathyroidism has never been settled. ‘Bilateralists’ oppose less invasive
approaches because  they estimate the incidence of multiple gland disease to be
as high as 30% 4. However, in spite of a systematic bilateral exploration of the
neck in search of the diseased parathyroid gland, with identification and estima-
tion of the size of all parathyroid tissue, in only 44% of cases are four glands iden-
tified, in 37% three, and in 19% less than three 5.
In chapter 1 we reported an exceptional case of persistent hyperparathyroidism
(due to a non-descended inferior parathyroid) after extensive bilateral exploration,
illustrating a clinical dilemma that can be encountered in parathyroid surgery.
Imaging carried out  prior to re-exploration and including, among other methods,
ultrasonography and computed tomography, revealed a parathyroid adenoma at
the level of the mandibular angle and the hyoid bone. Guided by the imaging
results the adenoma was successfully resected by a local direct procedure taking
less than 10 minutes.
In general, the main reason an adenoma is not found during exploration is the vari-
ability in location, rather than variety in the number of glands. It is therefore of piv-
otal importance to understand not only the anatomy, but also the embryology of
the parathyroid glands. As radiologist John Doppman succinctly stated, ‘If you are
an experienced parathyroid surgeon and not able to find a tumor, you cannot have
looked high enough’.
Since primary hyperparathyroidism can be diagnosed with nearly 100% accuracy
and successfully treated in more than 95% of cases, surgery is the treatment of
choice. The gold standard in parathyroid surgery has been conventional neck
exploration (CNE), and with success rates exceeding 95% and virtually no compli-
cations nothing more seemed left to be desired. However, it cannot be denied that
there is a discrepancy between the extent of the operation and the size of the
offending gland in the majority of patients 6. Encouraged by the pace of develop-
ment in methods of imaging (resulting in increased accuracy), combined with the
knowledge that primary hyperparathyroidism is caused by a solitary adenoma in at
least 85% of cases, and our experience of the relatively simple and quick MIA pro-
cedure (chapter 1)  we wondered whether such a direct, minimally invasive strate-
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gy could be utilized for the more common cases of primary hyperparathyroidism as
well.
For this purpose we formulated the following hypothesis (chapter 3): ‘A substantial
group of patients with primary hyperparathyroidism can be successfully treated by
limited access surgery after preoperative localization studies and may thus be
spared unnecessary extensive dissection (conventional neck exploration)’.
Minimally invasive adenomectomy
We prospectively tested this minimally invasive approach as an alternative to CNE.
In chapter 4 we described the results of 110 consecutive patients who underwent
parathyroidectomy, 84 of whom were selected for minimally invasive adenomecto-
my (MIA) and 26 for CNE. Operating time was 20 minutes in the MIA group and
80 minutes in the CNE group (p<0.05), and admission days were reduced to 1.7
days (MIA group) from 3.0 (CNE group) (p<0.05). MIA was shown to be a safe
and effective technique with a success rate of 96%, capable of replacing conven-
tional neck exploration in approximately 75% of patients, with virtually no compli-
cations. Several other investigators have proposed less invasive strategies as
alternatives for CNE, most of which have focused on unilateral neck exploration 3.
True minimally invasive techniques were reported to be feasible, guided by preop-
erative ultrasonography, in about 40% of cases 8, while others have reported excel-
lent results using intraoperative sestamibi-technetium99m scintigraphy
(Sestamibi) parathyroid scanning with a hand-held gamma probe 9. Though attrac-
tive when the neck has to be reoperated on due to failure of an initial exploration,
in our opinion the costs associated with the Sestamibi scanning preclude its rou-
tine use, as discussed below. Alternatively, some surgeons have advocated
endoscopy to achieve minimally invasive adenomectomy in selected patients 10.
Although conceptually elegant, this technique appears difficult to learn and certainly
requires more operating time than the direct approach described in this thesis.
CHAPTER 10 I SUMMARY, DISCUSSION
107
10. hoofdstuk 10  23-07-2001  09:50  Pagina 107
Asymptomatic and mildly symptomatic patients
The 1990 National Institute of Health (NIH) Consensus Development Conference
arrived at a consensus on the indications for surgical intervention in asymptomatic
primary hyperparathyroidism 10. Among their findings, the panel concluded that
the diagnosis of primary hyperparathyroidism does not mandate referral for opera-
tive intervention in all cases. Conscientious surveillance was thought to be justified
in asymptomatic patients whose calcium levels are only mildly elevated (to < 3.0
mmol/L; normal 2.20-2.60), and whose renal and bone status are close to normal
(creatinine clearance reduced not more than 30% and bone mass not more than
two standard deviations below those of controls matched for age, sex, and ethnic
origin.
Nevertheless, patients with primary hyperparathyroidism have significant function-
al health status impairment independent of the level of serum calcium 11. In addi-
tion, our experience with MIA has provided us with new arguments for making it
the surgical option of choice in asymptomatic and mildly symptomatic patients. In
chapter 5 we advised the following strategy for the asymptomatic or mildly symp-
tomatic patient. When a patient has biochemically proven hypercalcemia with
inappropriate levels of parathormone (PTH), localization of the adenoma has to be
attempted by Doppler-ultrasonography and computed tomography. When test
results unequivocally indicate a solitary adenoma the patient is advised to undergo
a minimally invasive procedure. However, if the test results are equivocal or indi-
cate the possibility of multiglandular involvement a conservative policy is advocat-
ed. If the disease advances, major symptoms develop and/or the patient fulfills the
NIH-guidelines, parathyroid imaging should be repeated before whichever form of
operation is indicated.
Imaging
Before the introduction of imaging-guided, minimally invasive parathyroid surgery,
the general opinion about preoperative localizing studies was that imaging before
initial surgery was not worthwhile. This objection to the routine use of localizing
tests was based on 1) inferior sensitivity rates in localizing studies (reaching 85%
maximum) when compared with success rates in conventional neck exploration
(over 95%); 2) the reduced accuracy of localizing studies in multiglandular dis-
ease; 3) an unjustified economic burden because of lack of evidence for the cost
effectiveness of imaging studies; and 4) the possibillity of misleading less experi-
enced surgeons 10 12 13 14. Now, a decade after the NIH meeting, some of these argu-
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ments may be viewed critically.
Firstly, most of these studies were carried out retrospectively and none followed a
strict protocol. Modern, state-of-the-art imaging modalities and prospective adher-
ence to a strict protocol gives, in our experience, good results. Furthermore, a team
approach with a dedicated radiologist and an experienced endocrine surgeon has
contributed considerably to the success of direct adenomectomy. In our series
ultrasonography gave a sensitivity of 78%, a specificity of 78% and a positive pre-
dictive value of 96% (chapter 6). Despite the fact that the combined results of
ultrasonography and computed tomography moderately improved the sensitivity to
84% (chapter 4), the diagnostic use of spiral computed tomography was advised
with caution, because of the associated costs and risks of radiation (chapter 6).
Nevertheless, the routine employment of both techniques can be justified because
1) computed tomography produces an operator-independent roadmap, and 2) with
the use of ‘cine-loop’ reconstruction at the computer work-station, additional infor-
mation and an essential three-dimensional view are available, helping the surgeon
in planning the operation.
Secondly, imaging (in our series ultrasonography combined with computed tomog-
raphy) was shown to be beneficial in preoperative planning for the treatment of pri-
mary hyperparathyroidism since, with its aid, we were able to select approximately
75% of patients for minimally invasive adenomectomy.
Thirdly, economic evaluations were limited in number and, if available, mostly
based on bilateral explorations.
On the basis of our personal favorable results we adhered strictly to the use of
ultrasonography combined with computed tomography. However, this does not
preclude the use of other modalities in the treatment of primary hyperparathy-
roidism. Parathyroid scanning using radioisotopes has evolved over the years and
is able to localize adenomas in approximately 90% of cases 15 16. The use of a
hand-held gamma probe (Sestamibi) to guide the surgeon to the parathyroid ade-
noma has been advocated as being useful in reoperations on the neck 17. Moreover,
excellent cure rates have also been reported with the use of a gamma probe in ini-
tial surgery, simultaneously decreasing operating time and hospital stay, resulting
in significant cost reduction without compromising patient safety 9 18. Conventional
scintigraphy (thallium201-technetium-Tc99m pertechnetate scanning) is, in our
opinion, not suitable for selecting patients for MIA because of the relatively poor
image resolution and anatomical information obtained. Sestamibi, has been report-
ed to give sensitivity rates up to 100% in solitary disease 14, but, in our opinion, it
should be restricted to a selected group of patients because of its high costs (+/- €
680). The modest increase in accuracy using Sestamibi does not justify the dispro-
portionate rise in cost.
Other imaging modalities consist of magnetic resonance imaging (MRI) and selec-
tive venous catheterization for measurement of PTH levels. Although MRI (sensitiv-
CHAPTER 10 I SUMMARY, DISCUSSION
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ity 57-90%) is only marginally more accurate than computed tomography (sensi-
tivity 41-86%) 13 19, MRI avoids the need for use of contrast medium and shoulder
artifacts are circumvented, we prefer computed tomography for  reasons of avail-
ability and cost. Finally, since selective PTH sampling requires an expert radiolo-
gist, is invasive and associated with high costs, its use should be restricted to
reoperations.
Parathormone assay
The clinical utility of rapid PTH measurement in parathyroid surgery was first
reported in 1988, using a modified intact PTH immunoradiometric assay 20. The
authors concluded that intraoperative measurement of PTH would be helpful to the
surgeon. The combination of more accurate preoperative localization studies and
the ability to predict the postoperative serum calcium would facilitate limited
explorations 3. The use of non-radioactive kits transportable on a trolley has
allowed the rapid assay to be performed in or adjacent to the operating theatre.
These commercially available portable kits measure PTH within 15 minutes with
sensitivity rates reaching 96%, specificity of 100% and overall accuracy of 97% 21
22. Although it cannot be denied that these tests are highly effective providing true
intraoperative results, the preliminary procedures (e.g. instrument performance
check, generating calibration curves and assay quality control prior to surgery),
and their substantial cost preclude their widespread introduction. In a search for a
less costly alternative rapid PTH assay, we studied the reliability and applicability
of a non-portable rapid PTH assay to predict successful surgical treatment of pri-
mary hyperparathyroidism (chapter 7). In that chapter we described the results of
the first 35 patients measured with a rapid PTH assay (modified Immulite Regular
assay) providing results within 70 minutes. Once the results were shown to agree
fully  with both conventional PTH measurements and postoperative serum calcium
levels, we included the Immulite Regular assay in our protocol. We also tested
three other non-portable PTH assays (Immulite Turbo, Advantage Regular and
Advantage Turbo assays), which are described in chapter 8. All these methods
were concluded to be useful to ascertain the success of an exploration. The
Immulite Regular and Immulite Turbo assays, however, were believed to be more
accurate than the Advantage Regular and Advantage Turbo assays when used
according to our protocol (a decline in PTH of >50%, measured 8 minutes after
resection, predicting normocalcemia).
110
10. hoofdstuk 10  23-07-2001  09:50  Pagina 110
Costs
Minimally invasive adenomectomy has definitely entered the therapeutic regimens
for  primary hyperparathyroidism, and therefore it is important to study the eco-
nomic burden. We cost-analyzed a prospective series of 164 patients to obtain
information on the relative costs of  MIA and CNE (chapter 9). To observe the
effect of changing appreciable variables, multiple sensitivity analyses were carried
out. The mean cost of MIA was calculated as € 1,288 and that of CNE € 2,106
(p<0.0005). The reason MIA is so much cheaper than CNE is the differences in
operating time (median 20 minutes in MIA versus 75 minutes in CNE) and admis-
sion days (2 days in MIA versus 3 days in CNE). Sensitivity analyses showed that
an increase in total average costs of 63%, an increase in operating time to 272
minutes, prolongation of admission from 2 to 4.5 days, or an initial operation fail-
ure rate of 54% in the MIA group would result in MIA costs equaling those for
CNE. Such extreme examples are clearly unrealistic, but admission time remains a
variable that is highly dependent on ‘local’ logistics, and may be amenable to
reduction. In particular, day care surgery will shortly become possible for MIA, pro-
vided a safe protocol for the management of postoperative hypocalcemia can be
designed (and adhered to).
The future
The ongoing technical developments of imaging modalities presage an increase in
discriminating capacity and increasing accuracy of various techniques, making
MIA possible for even more patients. The possibility of day-care MIA, using intra-
venous sedation combined with local anesthesia, will further liberalize the indica-
tions for this method.
Conclusion
In conclusion, minimally invasive adenomectomy is a safe and effective alternative to
conventional neck exploration, able to replace it in approximately 75% of cases. It is
not only associated with a very low complication rate, comparable to that of conven-
tional neck exploration, but is also cheaper than conventional exploration. In the
future, additional savings may be anticipated when day-care MIA becomes possible.
CHAPTER 10 I SUMMARY, DISCUSSION
111
10. hoofdstuk 10  23-07-2001  09:50  Pagina 111
References
1 Wang CA. Surgical management of primary hyperparathyroidism. Curr Prob Surg
1985; 22: 1-50
2 Tibblin S, Bondeeson AG, Ljungberg O. Unilateral parathyroidectomy in hyperparathy-
roidism due to single adenoma. Ann Surg 1982; 195: 245-252
3 Irvin GL III, Prudhomme DL, Deriso GT, et al. A new approach to parathyroidectomy.
Ann Surg 1994; 219: 574-581
4 Bruining HA, van Houten H, Juttmann JR, et al. Results of operative treatment of 615
patients with primary hyperparathyroidism. World J Surg 1981; 5: 85-90
5 Van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an
institutional perspective. World J Surg 1991; 15: 688-692
6 Van Vroonhoven TJMV, van Dalen A. Successful minimally invasive surgery in
primary hyperparathyroidism after combined preoperative ultrasound and computed
tomography imaging. J Int Med 1998; 243: 581-587
7 Lucas RJ, Welsh RJ, Glover JL. Unilateral neck exploration for primary hyperparathy-
roidism. Arch Surg; 125: 982-985
8 Chapuis Y, Icard P, Fulla Y et al. Parathyroid adenomectomy under local anesthesia with
intraoperative monitoring of UcAMP and/or 1-84 PTH. World J Surg 1992; 16: 570-575
9 Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguid-
ed parathyroidectomy on efficacy, length of stay, and costs in the management of pri-
mary hyperparathyroidism. Ann Surg 2000; 231: 732-742
10 Consensus Development Conference Panel. Diagnosis and management of asympto-
matic hyperparathyroidism: consensus development conference statement. Ann Int
Med 1991; 114: 593-597
11 Burney RE, Jones KR, Christy B, Thompson NW. Health status improvement after sur-
gical correction of primary hyperparathyroidism in patients with high and low preopera-
tive calcium levels. Surgery 1999; 125: 608-614
12 Roe SM, Burns P, Graham LD, et al. Cost-effectiveness of preoperative localization
studies in primary hyperparathyroidism disease. Ann Surg 1994; 219: 582-586
13 Miller DL. Preoperative localization and interventional treatment of parathyroid tumors:
when and how? World J Surg 1991; 15: 706-715
14 Casas AT, Burke GJ, Mansberger AR jr, Wei JP. Impact of technetium-99m sestamibi
localization on operative time and success of operations for primary hyperparathy-
roidism. Am Surg 1994; 60: 12-16
15 Thulé P, Tharoke K, Vasant J, et al. Preoperative localization of parathyroid tissue with
technetium-99m sestamibi 123I substraction scanning. J Clin Endocrinol Metab 1994;
78: 77-82
16 Denham DW, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary
hyperparathyroidism is dependent solely upon the surgeon’s choice of operative proce-
dure. J Am Coll Surg 1998; 186: 293-305
112
10. hoofdstuk 10  23-07-2001  09:50  Pagina 112
17 Norman J, Denham D. Minimally invasive radioguided parathyroidectomy in the reop-
erative neck. Surgery 1998; 124: 1088-1093
18 Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a
combination of sestamibi-spect localization, cervical block anesthesia, and intraopra-
tive parathyroid hormone assay. Surgery 1999; 126; 1016-1021
19 Krubsack AJ, Wilson SD, Lawson TC, et al. Prospective comparison of radionuclide,
computed tomography and sonographic localization of parathyroid tumors. World J
Surg 1986; 10: 579-585
20 Nusbaum SR, Thompson AR, Hutcheson KA, et al. Intraoperative measurement of
parathyroid hormone in the surgical management of hyperparathyroidism. Surgery
1988; 104: 1121-1127
21 Irvin III GL, Deriso III GT. A new, practical intraoperative parathyroid hormone assay.
Am J Surg 1994; 168: 466-468
22 Boggs JE, Irvin GL III, Molinari AS, Deriso GT. Intraoperative parathormone monitoring
as an adjunct to parathyroidectomy. Surgery 1996; 120: 954
CHAPTER 10 I SUMMARY, DISCUSSION
113
10. hoofdstuk 10  23-07-2001  09:50  Pagina 113
114
10. hoofdstuk 10  23-07-2001  09:50  Pagina 114
Samenvatting (voor de niet ingewijde)
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Introductie
In de hals, net achter de schildklier, liggen de vier bijschildklieren. Deze kliertjes
maken het parathormoon (PTH), dat van invloed is op de kalkhuishouding van het
lichaam. Wanneer één (of meerdere) bijschildklier (en) te snel gaat (gaan) werken,
wordt deze groter (adenoom) en maakt te veel PTH met als gevolg een stijgend
kalkgehalte in het bloed. Dit ziektebeeld heet primaire hyperparathyreoïdie (pHPT)
en gaat bij ongeveer 30-40 % van de patiënten gepaard met de volgende klachten:
urinestenen, pijn in de botten, verminderd algemeen welzijn (moeheid, vermin-
derde eetlust, depressie), buikklachten en obstipatie. Een sterk verhoogd kalkge-
halte kan zelfs levensbedreigend zijn.
De therapie voor deze ziekte is chirurgisch waarbij het adenoom wordt verwijderd
teneinde het kalkgehalte in het bloed te normaliseren. De klassieke operatie hier-
voor is de conventionele hals exploratie, een procedure waarbij via een ongeveer
12 cm grote incisie in de hals, alle vier de bijschildklieren worden opgezocht, door
de chirurg worden beoordeeld op grootte (en dus functie), waarna het adenoom
wordt verwijderd. Deze procedure duurt ongeveer anderhalf uur, is uitermate suc-
cesvol (tenminste 95% genezing), veilig (weinig complicaties) en gaat gepaard met
een ziekenhuis opname van 2 tot 3 dagen.
Bij tenminste 85% van de patiënten met pHPT is maar één bijschildklier ziek (en
zijn er drie gezond). Wanneer de chirurg vóór operatie zou weten om welke klier
het gaat, zou hij/zij kunnen volstaan met het opzoeken en verwijderen van alleen
deze klier. Dan worden de gezonde klieren niet meer opgezocht met als gevolg een
beperktere ingreep waardoor 1) de operatie duur korter wordt, 2) patiënten eerder
het ziekenhuis verlaten en 3) het litteken kleiner wordt. 
In hoofdstuk 1 wordt een casus beschreven waarbij, ondanks een zeer uitgebreide
operatie uitgevoerd door een zeer ervaren chirurg, het adenoom niet kon worden
gevonden. Bij deze operatie werden drie gezonde klieren gevonden, maar de vierde
(en dus zieke) kon ondanks alle inspanningen niet worden geïdentificeerd. Na de
ingreep bleef het kalk in het bloed verhoogd, waarop de patiënt werd doorver-
wezen naar het Universitair Medisch Centrum in Utrecht. In een poging het ade-
noom preoperatief in beeld te brengen (localiseren) werd (onder andere) een
echografie en CT van de hals verricht. De radioloog vond bij echografie het ade-
noom op een zeer ongebruikelijke plek, hoog in de hals. Nadat dit werd bevestigd
met CT onderzoek kon het adenoom op betrekkelijk simpele wijze, via een incisie
van anderhalve cm in minder dan 10 minuten, worden verwijderd.
Aangemoedigd door deze ervaring, de wetenschap dat in tenminste 85% van de
gevallen de ziekte wordt veroorzaakt door maar één adenoom en het gegeven dat
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de kwaliteit van beeldvormende technieken sterk is verbeterd, ontwikkelden wij
een beperkte, minimaal invasieve operatie techniek voor patiënten met pHPT. 
In hoofdstuk 3 werd de volgende hypothese geformuleerd ‘Bij een substantieel
aantal patiënten met pHPT kan, na preoperatieve beeldvorming worden volstaan
met een minimaal invasieve verwijdering van het bijschildklier adenoom waardoor
een onnodig grote ingreep (conventionele hals exploratie) wordt vermeden’.
Minimaal invasieve bijschildklier chirurgie
In hoofdstuk 4 beschrijven we de resultaten van de eerste 110 patiënten die we in
de periode oktober 1994 tot oktober 1998 opereerden voor pHPT. Na beeldvorm-
ing (echografie en CT) werden vierentachtig (76%) patiënten geselecteerd voor de
minimaal invasieve ingreep, 26 voor de conventionele ingreep. De mediane duur
van de minimaal invasieve ingreep was 20 minuten versus 80 minuten (p<0,05)
bij de conventionele ingreep. De mediane opnameduur reduceerde van 3,0 dag
(conventionele groep) naar 1,7 dag (p<0,05). Het succes percentage
(gedefinieerd als postoperatieve normalisatie van het kalkgehalte in het bloed,
gemeten op de eerste dag na operatie en bevestigd 1 week en 1 maand na oper-
atie) was 96%. De minimaal invasieve ingreep was even veilig als de conven-
tionele ingreep. 
De  niet symptomatische en mild symptomatische patiënt
Consensus over indicaties voor chirurgisch ingrijpen bij pHPT werd bereikt op de
‘National Institute of Health (NIH) Consensus Development Conference on Primary
Hyperparathyroidism’, welke werd gehouden in 1990 (Verenigde Staten). Eén van
de conclusies die werd getrokken was dat niet alle patiënten in aanmerking kwa-
men voor chirurgie, maar dat chirurgisch ingrijpen gerechtvaardigd is indien 1) het
kalkgehalte in het bloed een bepaalde grens passeert (>3,00 mmol/L), 2) er
sprake is van (evidente) klachten, 3) er door de ziekte een bepaalde mate van
botontkalking optreedt of 4) de nierfunctie als gevolg van de ziekte verslechtert
(beneden een bepaalde grens). Een afwachtend beleid werd geadviseerd indien
niet aan (één van) de criteria wordt voldaan. 
Met de introductie van de minimaal invasieve ingreep verdwijnt echter een aantal
nadelen van operatie. Immers, vergeleken met de conventionele ingreep is de mini-
maal invasieve ingreep kleiner en dus minder belastend voor de patiënt. Dit in
combinatie met het feit dat een verhoogd kalkgehalte in het bloed de gezondheid
op den duur ten nadele beïnvloedt en de vraag (die velen zich stellen) of patiënten
zonder enige symptomen werkelijk bestaan (met andere woorden iedereen met de
ziekte heeft klachten maar is zich daarvan niet altijd bewust omdat 1) de klachten
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vaag zijn en 2) ze langzaam zijn ontstaan), pleiten voor een meer liberaal beleid
ten aanzien van chirurgische therapie. In hoofdstuk 5 wordt, voor die patiënten die
geclassificeerd worden als a-symptomatisch of weinig symptomatisch de volgende
strategie voorgesteld; Nadat de diagnose pHPT is gesteld ondergaat de patiënt
localiserend onderzoek (echografie en CT). Wanneer er (zonder twijfel) sprake is
van één adenoom wordt de patiënt gepland voor de minimaal invasieve methode.
Wordt het adenoom bij beeldvorming niet gevonden, of bestaat er onzekerheid of
een in beeld gebrachte afwijking een adenoom danwel een andere structuur is, of
indien er sprake is van meerdere adenomen (dus een conventionele ingreep moet
worden uitgevoerd) wordt een terughoudend beleid gevoerd. Indien de ziekte ver-
volgens verslechtert (b.v. verergering van de symptomen, kalkgehalte stijgt boven
3,00 mmol/L), wordt de patiënt opnieuw aangeboden voor beeldvorming gevolgd
door chirurgisch ingrijpen.
Preoperatieve beeldvorming
De opinie over het nut van beeldvorming voorafgaand aan bijschildklier chirurgie
(conventionele hals exploratie) was, vóór de introductie van minimaal invasieve
methoden, dat het geen additionele waarde had om het succes van de ingreep te
garanderen. De motivatie hiervoor was dat 1) de gevoeligheid van de beeldvor-
mende technieken (sensitiviteit maximaal 85%) lager was dan het succes van de
conventionele ingreep (tenminste 95% zonder preoperatieve beeldvorming), 2) de
gevoeligheid verder afnam wanneer er sprake was van meer dan één adenoom, 3)
bewijzen voor kosten effectiviteit van beeldvorming ontbraken en 4) beeldvorming
de minder ervaren chirurg op het verkeerde been kon zetten.
Deze feiten waren echter gebaseerd op 1) retrospectief materiaal en 2) resultaten
behaald met (inmiddels) verouderde apparatuur. Het gebruik van nieuwe ‘state of
the art’ apparatuur, goede communicatie tussen radioloog en chirurg en een
degelijk prospectief protocol leidt (in onze ervaring) tot de volgende resultaten;
selectie voor minimaal invasieve chirurgie bij ongeveer driekwart van de patiënten,
sensitiviteit en specificiteit van echografie 78%, positief voorspellende waarde
96% (hoofdstuk 6). Hoewel de sensitiviteit van echografie en CT samen iets hoger
ligt (84%) (hoofdstuk 4) zijn er argumenten voor en tegen het routinematig gebruik
van CT die in dit proefschrift worden bediscussieerd. Als tegenargumenten worden
in hoofdstuk 6 genoemd de stralenbelasting voor de patiënt en de additionele
kosten die worden gemaakt terwijl de resultaten maar weinig verbeteren. Echter, in
tegenstelling tot echografie, zijn de resultaten van CT ‘onderzoeker onafhankelijk’
en kan met behulp van de computer (easy-vision werkstation) een goed driedimen-
sionaal beeld worden verkregen van het gescande gebied (hoofdstuk 4).
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Peroperatieve parathormoon bepalingen
Het succes van een ingreep wordt afgemeten aan een postoperatief normaal
kalkgehalte in het bloed. Nadat het adenoom is verwijderd daalt het kalkgehalte
langzaam (ongeveer 24 uur) naar normaal waarden. Om te weten of een ingreep is
geslaagd (en de patiënt is genezen) moet dus tot de volgende dag worden
gewacht. Wanneer een tweede adenoom bij beeldvorming wordt gemist zal deze
bij een minimaal invasieve ingreep niet worden verwijderd met als resultaat persis-
terende ziekte. Dan zal de patiënt op een later tijdstip een tweede operatie (in
eventueel) tweede opname moeten ondergaan. Om dit probleem te ondervangen is
een controle van chirurgisch handelen wenselijk. Wanneer een dergelijke test per-
sisterende ziekte voorspelt kan vervolgens in dezelfde sessie verder geëxploreerd
worden (conventionele exploratie) om het tweede (derde of vierde) adenoom te
verwijderen.
De halfwaarde tijd van het PTH is zeer kort (ongeveer 3 minuten). De  PTH con-
centratie in het bloed zal dus, nadat het adenoom is verwijderd, snel dalen. 
Door PTH spiegels van voor en na operatie te vergelijken kan een uitspraak worden
gedaan of al het te snel werkend weefsel is verwijderd. Een cito (snel) uitgevoerde
PTH meting kan dus als de gewenste snelle controle dienen. 
Het meten van dit hormoon op klassieke wijze neemt echter vele uren in beslag en
is derhalve niet geschikt als chirurgische controle. In hoofdstuk 7 worden de resul-
taten beschreven van een gemodificeerde PTH meetmethode (Immulite Regular
assay) die binnen 70 minuten resultaten levert en getest werd op betrouwbaarheid
en bruikbaarheid als gewenste voorspeller van chirurgisch handelen. Nadat deze
cito  PTH assay betrouwbaar bleek als chirurgische controle (100% correlatie
tussen PTH test en postoperatief kalkgehalte), werd het geïntegreerd in ons protocol.
Voor dit doel zijn verschillende cito PTH assays commercieel verkrijgbaar. Enkele
van deze kunnen worden verricht op de operatiekamer (portable assays) in plaats
van in het laboratorium (non-portable assays), met als voordeel dat geen (kost-
bare) tijd gaat verloren bij het transport van de bloedsamples van operatiekamer
naar laboratorium. Deze assays leveren weliswaar zeer snel (binnen 15 minuten)
test uitslagen, waardoor een echte intra-operatieve test ontstaat, ze zijn ook
(buiten proportioneel) duur (ongeveer 1.000 US dollar per patiënt).
Als alternatief voor deze ‘dure’ PTH assays testten wij vier (ongeveer 100 US dollar
per patiënt) (non-portable) laboratorium assays: Immulite Regular (test resultaten
<70 minuten, Immulite Turbo (test resultaten <20 minuten), Advantage Regular
(test resultaten <35 minuten) en Advantage Turbo (test resultaten <20 minuten).
In hoofdstuk 8 worden de resultaten van deze vier verschillende PTH testen
beschreven. Alle vier testen waren geschikt als snelle controle, echter de Immulite
Regular en Immulite Turbo assays waren in onze ervaring en wanneer getest vol-
gens de richtlijnen van ons protocol (dwz dat een PTH daling van meer dan 50%
moet zijn opgetreden wanneer 8 minuten na verwijdering van het adenoom het
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bloed wordt afgenomen en getest), nauwkeuriger dan Advantage Regular en
Advantage Turbo.
Kosten
In hoofdstuk 9 worden de resultaten van een kostenminimeringsanalyse en ver-
scheidene (univariate) gevoeligheidsanalyses beschreven. De gemiddelde kosten
voor de minimaal invasieve ingreep werden berekend op 1.288 Euro per patiënt
versus 2.106 Euro voor de conventionele ingreep. Met name het verschil in oper-
atietijd en opnameduur tussen beide methoden was verantwoordelijk voor dit prijs-
verschil. Pas wanneer de operatieduur van de minimaal invasieve methode wordt
verlengd tot 272 minuten, of de opnameduur wordt verlengd tot vier en een halve
dag, of 54 % van alle minimaal invasieve ingrepen mislukt, worden de kosten van
de minimaal invasieve methode gelijk aan die van de conventionele methode.
De toekomst
Verdere verbeteringen op het gebied van beeldvormende technieken zullen resul-
teren in toenemende gevoeligheid en een groter onderscheidend vermogen waar-
door, in de toekomst, meer patiënten met pHPT geselecteerd kunnen worden voor
minimaal invasieve chirurgie. Dit in combinatie met de mogelijkheid patiënten in
dagopname onder lokaal anaesthesie te opereren zal bijdragen aan verdere liberal-
isatie van indicatie voor chirurgisch ingrijpen
Conclusie
Minimaal invasieve bijschildklier chirurgie is even veilig en goed als de conven-
tionele hals exploratie. Het vervangt de conventionele hals exploratie bij driekwart
van alle patiënten met pHPT, is goedkoper waarbij in de toekomst verdere
kostenbesparing mag worden verwacht wanneer de ingreep zal worden uitgevoerd
in dagbehandeling.
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Dankwoord
Het schrijven van een proefschrift is onmogelijk zonder de hulp en inspanningen
van velen. Aan allen ben ik veel dank verschuldigd, een aantal wil ik met name
noemen;
Prof. dr Th.J.M.V. van Vroonhoven. 
Beste professor, bij u promoveren, nota bene op het gebied van de bijschildklieren
ervaar ik als een groot voorrecht en genoegen. Ik ben u niet alleen dankbaar voor
uw begeleiding bij mijn promotie maar zeker ook voor uw aandeel en betrokken-
heid in zowel mijn opleiding tot algemeen chirurg als in het dagelijks leven.
Drs. A. van Dalen. 
Beste Bert, jij als de andere ‘architect’ van bijschildklier chirurgie ‘nieuwe stijl’
hebt met je streven naar perfectie een belangrijk aandeel in dit geslaagde project.
Ik heb met plezier met je samengewerkt en ben je dankbaar voor je tomeloze inzet
die heeft geleid tot mijn promotie.
Dr I.H.M. Borel Rinkes. 
Beste Inne, eindelijk is het dan zover. Regelmatig zaten we naast elkaar, we sprak-
en dan honderd-uit en behalve over de wetenschappelijke vorderingen met name
veel over ‘van die dingen in het leven’. En behalve dat ik dit iedere keer weer
onwaarschijnlijk gezellig vond/vindt, wist je me telkens weer, gewapend met frisse
moed de goede kant op ‘te duwen’. Inne, veel dank, zowel voor je wetenschap-
pelijke inbreng als voor je vriendschap !
Prof. dr Chr. van der Werken. 
Beste professor, op uw vraag ‘wat kom je doen’ (8 januari 1996, 07.15 uur) kan
ik nu een beter antwoord geven dan toen: ‘promoveren en chirurg worden, profes-
sor’. Dank voor uw betrokkenheid (en geduld) gedurende mijn AZU jaren.
De overige leden van de beoordelingscommissie. 
Prof. dr C.J.M. Lips, prof. dr J.H.H. Thijssen en prof. dr E.E. de Lange voor uw
interesse, betrokkenheid, enthousiasme en bijdragen die hebben geleid tot dit
proefschrift.
De afdeling Radiologie van het UMCU en met name de echolaboranten die mij
telkens weer trouw belden wanneer weer een echo werd gemaakt.
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De medewerkers van het endocrien laboratorium. Jullie enthousiasme,
vakkundigheid en betrokkenheid zijn de sleutel van het succes van peroperatieve
PTH’s. Met name wil ik John van Zon, Inge Maitimu en Hilda Compagner danken 
voor hun inspanningen die hebben geleid tot de ontwikkeling en realisatie van per-
operatieve PTH metingen.
De afgelopen jaren heb ik samengewerkt met een groot aantal medeassistenten in
zowel het Universitair Medisch Centrum Utrecht als het Diakonessenhuis Utrecht. 
Dankzij jullie collegialiteit heb ik de ruimte gehad die nodig was om deze studie te
voltooien. Niet alleen hiervoor ben ik jullie veel dank verschuldigd, maar ook voor
alle geleverde inspanningen (zoals het coördineren van PTH’s) en bovenal de
prima tijd die ik met jullie had / heb.
Eén ster aan het firmament wil ik met naam noemen en danken voor zijn inspan-
ningen rond de PTH coördinatie: Bram Fioole bedankt.
Dr M.S.L Liem. 
Beste Mike, het was goed zaken met je doen. Je wetenschappelijke kwaliteiten
bewezen zich maar al te vaak bij de kostenanalyse die we hebben uitgevoerd.
Hoewel je op dit gebied absoluut ‘superieur’ bent kan ik je aanraden in de
toekomst wat beter naar mij te luisteren wanneer het gaat over ‘beurs bewegin-
gen’. Alleen dan kan je pakket ‘robust’ van karakter worden.
I would like to thank Hugh and Amanda de Glanville for their effort in revising
parts of this thesis.
Dr H.F. Veen. 
Beste dr Veen, uw aandeel is groot. Niet alleen vanwege het leveren van
Rotterdamse patiënten aan de ‘para’ studie, maar zeker ook vanwege uw interesse
en betrokkenheid in de opleiding, promotie en bovenal het leven van Smit daar-
buiten. De vele telefoontjes, de Ikazia bezoeken en het jaarlijks terugkerend ritueel
binnen ‘de schoonste der schoone’ dragen bij aan het ‘senang’. Dr Veen, waarvoor
dank !
Mw C.K. Schoen-Obbink. 
Lieve TT, niet voor niets draag ik dit proefschrift onder andere aan u op. De liefde
waarmee u (en Rutger Jan, Michiel en Caroline -plus aanhang-) de gebroeders
Smit (en Sanne) heeft opgenomen in de Schoenen familie is groots en is van
onschatbare waarde. Het is een voorecht mensen als u als voorbeeld te hebben in
het leven. Lieve TT, dank.
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Tijs en Jelke Smit
Lieve broeders, dank voor jullie zorg, geduld en nimmer aflatende steun. 
Wordt het niet eens tijd dat jullie een feestje gaan geven ?
En natuurlijk mijn lieve Sanne. Mijn stralende zonnetje. En dat zie ik zo graag.
Want stralen kun je zo goed, dus blijf dat nog maar héél lang doen. Lief, dank je
voor de eerste 10.
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Curriculum Vitae
De schrijver van dit proefschrift werd geboren op 18 januari 1968 te Vlissingen.
Hij volgde zijn middelbare schoolopleiding aan het Eerste Vrijzinnig Christelijk
Lyceum te Den Haag, alwaar hij in 1986 zijn HAVO diploma behaalde, om vervol-
gens in 1987 zijn VWO diploma te halen aan het Noctua college te Den Haag. Dit
zelfde jaar werd met de studie Geneeskunde aan de Erasmus Universiteit
Rotterdam begonnen. Na het behalen van het artsexamen in december 1995
werkte hij vanaf januari 1996 als arts-assistent niet in opleiding op de afdeling
heelkunde van het Academisch Ziekenhuis Utrecht. Medio 1997 werd begonnen
met het onderzoek, hetgeen geleid heeft tot dit proefschrift. In januari 1998 werd
in het Academisch Ziekenhuis Utrecht gestart met de opleiding tot algemeen
chirurg (opleider: prof. dr Th.J.M.V. van Vroonhoven). Sinds januari 2001 volgt hij
de laatste drie jaar van zijn chirurgische opleiding in het Diakonessenhuis te
Utrecht (opleider: dr G.J. Clevers).
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